Abstract Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow. The ongoing epidemic of opioid use disorder includes, in addition to increasing global use of illicitly manufactured heroin and other opioids, a public health crisis aggravated by the over-prescribing of opioid pain medications, in North America particularly. This Primer by Strang, Volkow and colleagues discusses the risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment.
AbstractList Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow.The ongoing epidemic of opioid use disorder includes, in addition to increasing global use of illicitly manufactured heroin and other opioids, a public health crisis aggravated by the over-prescribing of opioid pain medications, in North America particularly. This Primer by Strang, Volkow and colleagues discusses the risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment.
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow.
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow. The ongoing epidemic of opioid use disorder includes, in addition to increasing global use of illicitly manufactured heroin and other opioids, a public health crisis aggravated by the over-prescribing of opioid pain medications, in North America particularly. This Primer by Strang, Volkow and colleagues discusses the risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment.
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow.Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow.
ArticleNumber 3
Author Marshall, Brandon D. L.
Johnson, Kimberly
Strang, John
Tyndall, Mark
Degenhardt, Louisa
Koob, George F.
Volkow, Nora D.
Walsh, Sharon L.
Hickman, Matthew
Author_xml – sequence: 1
  givenname: John
  surname: Strang
  fullname: Strang, John
  email: john.strang@kcl.ac.uk
  organization: National Addiction Centre, Institute of Psychiatry Psychology & Neuroscience, King’s College London, South London & Maudsley NHS Foundation Trust
– sequence: 2
  givenname: Nora D.
  surname: Volkow
  fullname: Volkow, Nora D.
  email: nvolkow@nida.nih.gov
  organization: National Institute on Drug Abuse, National Institutes of Health
– sequence: 3
  givenname: Louisa
  surname: Degenhardt
  fullname: Degenhardt, Louisa
  organization: National Drug and Alcohol Research Centre, University of New South Wales
– sequence: 4
  givenname: Matthew
  surname: Hickman
  fullname: Hickman, Matthew
  organization: Population Health Sciences, Bristol Medical School, University of Bristol
– sequence: 5
  givenname: Kimberly
  surname: Johnson
  fullname: Johnson, Kimberly
  organization: Department of Mental Health Law and Policy, College of Community and Behavioural Sciences, University of South Florida
– sequence: 6
  givenname: George F.
  surname: Koob
  fullname: Koob, George F.
  organization: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
– sequence: 7
  givenname: Brandon D. L.
  surname: Marshall
  fullname: Marshall, Brandon D. L.
  organization: Department of Epidemiology, Brown University School of Public Health
– sequence: 8
  givenname: Mark
  surname: Tyndall
  fullname: Tyndall, Mark
  organization: School of Population and Public Health, University of British Columbia
– sequence: 9
  givenname: Sharon L.
  surname: Walsh
  fullname: Walsh, Sharon L.
  organization: Department of Behavioral Science, College of Medicine, University of Kentucky
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31919349$$D View this record in MEDLINE/PubMed
BookMark eNp9kD1LAzEYgINUbK2dnFyk4OJymu_3MkrxCwpdFNxC7i4nKe2lJneD_96Uqx8U7BDeDM-TvDynaND4xiJ0QfANwSy_jZwIoBkmKh0GmThCI4qFzCTIt8Gf-xBNYlxijInIpcrlCRoyoohiXI3Q-WLjvKumXbTTykUfKhvO0HFtVtFOdnOMXh_uX2ZP2Xzx-Dy7m2clx7jNSJnjMmeFoqQuBAiwYInFlnIjlCSCs8IAVJUCYKXJa5nLooZEcKtqVnE2Rtf9u5vgPzobW712sbSrlWms76KmjEnKJVCZ0Ks9dOm70KTtNEs1MAcK5BBFGacMFE_wGF3uqK5Y20pvglub8Km_oySA9EAZfIzB1j8IwXrbXvftdWqvt-21SA7sOaVrTet80wbjVgdN2psx_dK82_C79P_SF069krc
CitedBy_id crossref_primary_10_1007_s40268_023_00443_5
crossref_primary_10_1097_JAN_0000000000000499
crossref_primary_10_3340_jkns_2021_0145
crossref_primary_10_1016_j_healthpol_2024_104993
crossref_primary_10_1016_j_drugalcdep_2022_109581
crossref_primary_10_1016_j_expneurol_2021_113710
crossref_primary_10_1001_jamanetworkopen_2024_51821
crossref_primary_10_3390_chemosensors12040058
crossref_primary_10_1016_j_etap_2022_103902
crossref_primary_10_4103_abr_abr_166_21
crossref_primary_10_1016_j_drugalcdep_2020_108499
crossref_primary_10_1016_j_jss_2024_07_089
crossref_primary_10_37349_eds_2024_00046
crossref_primary_10_1007_s13596_024_00771_0
crossref_primary_10_1097_j_pain_0000000000002280
crossref_primary_10_1007_s13346_022_01202_w
crossref_primary_10_14475_jhpc_2023_26_4_185
crossref_primary_10_1177_00220426241269828
crossref_primary_10_1016_j_bpsgos_2025_100476
crossref_primary_10_1177_0310057X211066929
crossref_primary_10_5812_jjcmb_121808
crossref_primary_10_1016_j_encep_2023_07_001
crossref_primary_10_3390_brainsci12080985
crossref_primary_10_1177_1357633X231195607
crossref_primary_10_1016_j_aan_2024_07_005
crossref_primary_10_4103_jfsm_jfsm_55_21
crossref_primary_10_1038_s41572_022_00406_1
crossref_primary_10_1080_14737167_2024_2350561
crossref_primary_10_1111_bph_15656
crossref_primary_10_1177_21582440251326348
crossref_primary_10_1007_s40140_020_00420_7
crossref_primary_10_1016_j_bpsgos_2025_100480
crossref_primary_10_1172_JCI172887
crossref_primary_10_3390_ijms24021633
crossref_primary_10_1016_j_dadr_2024_100218
crossref_primary_10_3390_ijms241310888
crossref_primary_10_1177_07067437221114094
crossref_primary_10_1016_j_jsat_2022_108851
crossref_primary_10_1007_s00213_025_06747_5
crossref_primary_10_1080_17425255_2020_1814737
crossref_primary_10_1016_j_josat_2023_209139
crossref_primary_10_1002_advs_202405352
crossref_primary_10_1016_j_cct_2024_107690
crossref_primary_10_1177_02698811241260989
crossref_primary_10_1097_j_pain_0000000000002860
crossref_primary_10_3389_fphar_2023_1241578
crossref_primary_10_2174_1871527321666220429122819
crossref_primary_10_3390_pharmacy11050164
crossref_primary_10_1080_13543776_2024_2446230
crossref_primary_10_1097_CCM_0000000000006189
crossref_primary_10_1016_j_neuroscience_2023_07_031
crossref_primary_10_1007_s40429_024_00588_6
crossref_primary_10_1016_j_drugpo_2025_104730
crossref_primary_10_1016_j_drugpo_2023_104255
crossref_primary_10_1080_10826084_2022_2076879
crossref_primary_10_1016_j_jen_2023_09_008
crossref_primary_10_1097_JXX_0000000000000944
crossref_primary_10_1016_j_therap_2020_12_009
crossref_primary_10_1038_s41380_022_01501_1
crossref_primary_10_1016_j_neuron_2022_09_024
crossref_primary_10_1093_cid_ciab578
crossref_primary_10_1136_bmjopen_2022_065646
crossref_primary_10_3389_fnbeh_2022_836996
crossref_primary_10_1016_j_cct_2025_107861
crossref_primary_10_1007_s10198_023_01661_z
crossref_primary_10_1007_s00414_024_03273_5
crossref_primary_10_1016_j_therap_2023_10_003
crossref_primary_10_1038_s41598_024_60759_3
crossref_primary_10_1111_adb_12982
crossref_primary_10_1016_j_pbb_2021_173294
crossref_primary_10_1111_bph_15677
crossref_primary_10_1016_j_drugalcdep_2021_108649
crossref_primary_10_1080_08897077_2021_1949663
crossref_primary_10_1002_pbc_29665
crossref_primary_10_1002_jcph_1923
crossref_primary_10_1038_s41386_023_01620_5
crossref_primary_10_57187_s_3629
crossref_primary_10_1001_jamanetworkopen_2021_9041
crossref_primary_10_1177_29767342241262556
crossref_primary_10_1089_tmj_2024_0122
crossref_primary_10_1016_j_focus_2024_100269
crossref_primary_10_1111_add_15636
crossref_primary_10_61186_jhc_24_3_193
crossref_primary_10_1111_adb_12977
crossref_primary_10_1016_j_drugalcdep_2020_108335
crossref_primary_10_1111_adb_12970
crossref_primary_10_1080_00952990_2023_2169616
crossref_primary_10_1080_10550887_2024_2431375
crossref_primary_10_3389_fphar_2023_1239159
crossref_primary_10_62401_2531_4122_2025_1
crossref_primary_10_1002_mco2_148
crossref_primary_10_1016_j_ajp_2023_103677
crossref_primary_10_1080_16066359_2024_2373138
crossref_primary_10_1007_s00520_023_07868_3
crossref_primary_10_1177_29767342241248926
crossref_primary_10_1177_10783903221145142
crossref_primary_10_1007_s40140_020_00414_5
crossref_primary_10_1016_j_vascn_2021_107101
crossref_primary_10_3389_fpsyt_2023_1247961
crossref_primary_10_1002_jsfa_13743
crossref_primary_10_1016_j_jneuroim_2023_578204
crossref_primary_10_1016_j_ynstr_2022_100431
crossref_primary_10_1177_26334895231199463
crossref_primary_10_3389_fpubh_2022_811001
crossref_primary_10_1016_j_biopsych_2021_08_005
crossref_primary_10_1016_j_drugalcdep_2020_108327
crossref_primary_10_1128_JVI_01657_20
crossref_primary_10_2147_PPA_S311674
crossref_primary_10_1016_j_therap_2020_05_007
crossref_primary_10_5694_mja2_52603
crossref_primary_10_1016_j_therap_2020_05_008
crossref_primary_10_1080_1533256X_2024_2378687
crossref_primary_10_1111_add_16616
crossref_primary_10_3389_fpsyt_2022_1003257
crossref_primary_10_1016_j_drugpo_2024_104343
crossref_primary_10_1108_FS_02_2023_0026
crossref_primary_10_1080_10550887_2021_2015053
crossref_primary_10_3390_molecules27165211
crossref_primary_10_1016_j_drugalcdep_2024_112535
crossref_primary_10_2196_57367
crossref_primary_10_1186_s13722_023_00402_0
crossref_primary_10_1080_17482631_2022_2094111
crossref_primary_10_1016_j_dadr_2023_100188
crossref_primary_10_1186_s12954_022_00671_z
crossref_primary_10_1002_ddr_21789
crossref_primary_10_1186_s12954_022_00656_y
crossref_primary_10_1080_00952990_2022_2043335
crossref_primary_10_3389_fpsyt_2024_1316108
crossref_primary_10_1038_s41593_022_01160_z
crossref_primary_10_1016_j_healthplace_2024_103296
crossref_primary_10_1016_j_jsat_2021_108646
crossref_primary_10_1007_s40122_023_00481_6
crossref_primary_10_1111_dar_13587
crossref_primary_10_1186_s12954_024_01005_x
crossref_primary_10_7759_cureus_42635
crossref_primary_10_1097_YCO_0000000000000870
crossref_primary_10_1007_s40429_025_00626_x
crossref_primary_10_1016_j_vaccine_2022_03_053
crossref_primary_10_3389_fnana_2024_1521016
crossref_primary_10_3389_fpsyt_2023_1258029
crossref_primary_10_3390_life14101227
crossref_primary_10_51982_bagimli_1203151
crossref_primary_10_1097_SPC_0000000000000743
crossref_primary_10_3390_healthcare12131268
crossref_primary_10_1016_j_biopsych_2024_05_020
crossref_primary_10_3390_v15030590
crossref_primary_10_1016_j_biopsych_2024_09_008
crossref_primary_10_1016_j_crneur_2021_100023
crossref_primary_10_1080_17441692_2020_1864750
crossref_primary_10_1016_j_addicn_2022_100034
crossref_primary_10_1021_acschemneuro_3c00750
crossref_primary_10_1080_10550887_2024_2354566
crossref_primary_10_1017_S003329172300332X
crossref_primary_10_1016_j_jconrel_2022_06_034
crossref_primary_10_1007_s00464_024_11057_6
crossref_primary_10_1016_j_jopan_2022_10_005
crossref_primary_10_1016_j_legalmed_2021_101911
crossref_primary_10_1016_j_drugpo_2024_104399
crossref_primary_10_1097_ADM_0000000000000768
crossref_primary_10_1080_16066359_2023_2282528
crossref_primary_10_1097_MD_0000000000031451
crossref_primary_10_1186_s13011_022_00434_w
crossref_primary_10_1080_16066359_2022_2132238
crossref_primary_10_1016_j_bbi_2021_12_014
crossref_primary_10_1016_j_cct_2023_107248
crossref_primary_10_1136_bmjopen_2020_046766
crossref_primary_10_1001_jamapsychiatry_2024_2176
crossref_primary_10_1080_14659891_2025_2474926
crossref_primary_10_36923_jicc_v23i3_122
crossref_primary_10_1007_s40263_024_01069_0
crossref_primary_10_1111_dar_13645
crossref_primary_10_1016_j_addbeh_2020_106681
crossref_primary_10_1186_s43045_022_00224_x
crossref_primary_10_1093_pubmed_fdac114
crossref_primary_10_1007_s11916_023_01105_6
crossref_primary_10_1016_j_pmn_2024_03_017
crossref_primary_10_1038_s41386_023_01793_z
crossref_primary_10_3389_fpsyt_2023_1205285
crossref_primary_10_7759_cureus_45415
crossref_primary_10_1016_j_dadr_2024_100298
crossref_primary_10_1016_j_gerinurse_2022_05_002
crossref_primary_10_3389_fpubh_2023_1274719
crossref_primary_10_1111_ppc_13030
crossref_primary_10_1097_CXA_0000000000000172
crossref_primary_10_3389_fphar_2022_819470
crossref_primary_10_2147_PRBM_S423802
crossref_primary_10_2196_37351
crossref_primary_10_1093_jalm_jfae169
crossref_primary_10_1007_s00213_024_06557_1
crossref_primary_10_35430_nab_2021_e14
crossref_primary_10_1016_j_pmedr_2023_102305
crossref_primary_10_3389_fpsyg_2021_595883
crossref_primary_10_1111_add_15377
crossref_primary_10_1111_add_15378
crossref_primary_10_1038_s41386_020_00927_x
crossref_primary_10_3389_fpsyt_2023_1224376
crossref_primary_10_1016_j_puhe_2023_07_004
crossref_primary_10_1177_1049732320938689
crossref_primary_10_1186_s13722_024_00527_w
crossref_primary_10_1016_j_neubiorev_2023_105280
crossref_primary_10_1016_j_mcna_2021_08_009
crossref_primary_10_1016_j_neuropharm_2021_108599
crossref_primary_10_1371_journal_pone_0265283
crossref_primary_10_1080_07853890_2022_2084154
crossref_primary_10_1002_emp2_12606
crossref_primary_10_3390_ijms26062519
crossref_primary_10_7759_cureus_75629
crossref_primary_10_1007_s00213_023_06447_y
crossref_primary_10_1159_000529926
crossref_primary_10_1542_pir_2022_005631
crossref_primary_10_1016_j_bbr_2023_114441
crossref_primary_10_1111_add_15818
crossref_primary_10_7759_cureus_28033
crossref_primary_10_1152_jn_00017_2021
crossref_primary_10_1097_YCO_0000000000000717
crossref_primary_10_1016_j_nurpra_2023_104914
crossref_primary_10_1093_ajhp_zxac269
crossref_primary_10_1007_s00213_024_06739_x
crossref_primary_10_1016_j_biopsych_2020_12_004
crossref_primary_10_1016_j_jns_2021_120094
crossref_primary_10_1097_FBP_0000000000000780
crossref_primary_10_1016_j_neuropharm_2021_108469
crossref_primary_10_1093_haschl_qxaf036
crossref_primary_10_1089_gtmb_2021_0280
crossref_primary_10_1186_s12913_024_10767_w
crossref_primary_10_1016_j_josat_2024_209396
crossref_primary_10_1097_ADT_0000000000000295
crossref_primary_10_1002_aet2_10756
crossref_primary_10_1080_10550887_2022_2044735
crossref_primary_10_1038_s41386_021_01200_5
crossref_primary_10_1186_s40352_024_00291_8
crossref_primary_10_1111_ajad_13455
crossref_primary_10_1126_sciadv_adq4779
crossref_primary_10_1111_bph_16043
crossref_primary_10_1038_s41591_020_0875_7
crossref_primary_10_3390_metabo11030189
crossref_primary_10_1016_j_bjane_2021_06_001
crossref_primary_10_62401_2531_4122_2024_18
crossref_primary_10_3389_fpsyt_2022_893303
crossref_primary_10_3389_fpsyt_2024_1505391
crossref_primary_10_1186_s12889_022_12685_0
crossref_primary_10_5055_jom_0898
crossref_primary_10_1016_j_bbr_2023_114385
crossref_primary_10_1016_j_drugalcdep_2023_111069
crossref_primary_10_1186_s13722_021_00261_7
crossref_primary_10_1177_20534345231213729
crossref_primary_10_1038_s41467_024_55504_3
crossref_primary_10_1089_tmj_2024_0410
crossref_primary_10_1007_s40265_020_01373_1
crossref_primary_10_1016_j_addicn_2024_100187
crossref_primary_10_1111_jcpp_13761
crossref_primary_10_1186_s12888_022_04283_6
crossref_primary_10_1001_jamahealthforum_2022_0093
crossref_primary_10_1097_j_pain_0000000000002878
crossref_primary_10_1038_s41572_020_0175_z
crossref_primary_10_1016_j_addicn_2024_100182
crossref_primary_10_3390_brainsci12091166
crossref_primary_10_1111_add_16574
crossref_primary_10_2139_ssrn_4116414
crossref_primary_10_1016_j_tips_2022_03_002
crossref_primary_10_1016_j_neubiorev_2021_04_019
crossref_primary_10_12688_wellcomeopenres_16431_2
crossref_primary_10_7759_cureus_50634
crossref_primary_10_12688_wellcomeopenres_16431_1
crossref_primary_10_1016_j_bbr_2021_113688
crossref_primary_10_54393_pjhs_v4i09_1030
crossref_primary_10_1080_23279095_2024_2336195
crossref_primary_10_1080_14728222_2023_2247563
crossref_primary_10_1097_FBP_0000000000000715
crossref_primary_10_54393_tt_v4i04_184
crossref_primary_10_1159_000519939
crossref_primary_10_1016_j_biomaterials_2024_123041
crossref_primary_10_1136_bmjopen_2022_069778
crossref_primary_10_1016_j_jadohealth_2023_08_047
crossref_primary_10_1515_nipt_2023_0004
crossref_primary_10_1002_dta_3104
crossref_primary_10_1016_j_jpain_2023_05_001
crossref_primary_10_1007_s11916_022_01073_3
crossref_primary_10_1080_00952990_2024_2360984
crossref_primary_10_1016_j_josat_2024_209338
crossref_primary_10_1007_s11469_024_01257_5
crossref_primary_10_1097_BOR_0000000000000868
crossref_primary_10_1210_endrev_bnae023
crossref_primary_10_1126_science_abn7065
crossref_primary_10_1186_s13033_023_00601_x
crossref_primary_10_1136_bmjopen_2021_059328
crossref_primary_10_1136_bmjopen_2021_060522
crossref_primary_10_1186_s13063_022_06595_0
crossref_primary_10_1001_jamanetworkopen_2024_55165
crossref_primary_10_5055_jom_0876
crossref_primary_10_1016_j_drugpo_2024_104651
crossref_primary_10_1016_j_drugalcdep_2024_112495
crossref_primary_10_2147_IJGM_S295461
crossref_primary_10_3390_ijms231911804
crossref_primary_10_1016_j_encep_2024_07_003
crossref_primary_10_1186_s13722_024_00475_5
crossref_primary_10_3390_healthcare10020223
crossref_primary_10_1016_j_addbeh_2022_107433
crossref_primary_10_1038_s41380_022_01837_8
crossref_primary_10_1016_j_oooo_2024_07_013
crossref_primary_10_3389_fpsyt_2022_999199
crossref_primary_10_1186_s12875_024_02607_x
crossref_primary_10_1186_s13256_024_04483_6
crossref_primary_10_1016_j_josat_2024_209588
crossref_primary_10_62401_2531_4122_2024_54
crossref_primary_10_1377_hlthaff_2020_00378
crossref_primary_10_2196_58723
crossref_primary_10_1016_j_jphs_2023_02_003
crossref_primary_10_1016_j_peh_2024_100275
crossref_primary_10_1016_j_drugpo_2022_103872
crossref_primary_10_1016_j_ajem_2023_06_005
crossref_primary_10_1097_TA_0000000000004180
crossref_primary_10_3389_fncel_2024_1403326
crossref_primary_10_1016_j_pmn_2023_11_002
crossref_primary_10_1080_17425247_2024_2369756
crossref_primary_10_1016_j_josat_2023_209177
crossref_primary_10_1126_sciadv_adr3567
crossref_primary_10_1016_j_therap_2024_09_003
crossref_primary_10_1016_j_ajog_2021_06_067
Cites_doi 10.1016/S2352-3018(18)30168-1
10.1007/BF02245289
10.15585/mmwr.mm6817a3
10.1016/S0740-5472(97)00016-0
10.1111/add.13238
10.1016/j.jsat.2008.09.007
10.1007/978-3-642-41199-1_22
10.1111/add.12337
10.1111/j.1360-0443.1992.tb02743.x
10.1081/ADA-100107660
10.1177/0193841X07307315
10.1136/bmj.e2502
10.1016/j.drugpo.2017.05.023
10.1136/bmj.293.6539.103
10.1038/scientificamerican0304-78
10.1016/j.jsat.2014.05.006
10.1038/nn1578
10.1007/BF01447558
10.1016/j.drugalcdep.2013.08.006
10.1016/j.drugalcdep.2005.11.007
10.1111/j.1360-0443.2011.03575.x
10.1086/449116
10.1111/add.14664
10.1016/S0140-6736(11)60358-9
10.15288/jsad.2015.76.909
10.1016/S1473-3099(16)30325-5
10.1016/S0893-133X(00)00186-X
10.1016/S0306-4522(02)00105-7
10.1111/j.1360-0443.2004.00752.x
10.1007/s002130000637
10.1016/j.drugalcdep.2005.01.013
10.1136/bmj.i19
10.1016/j.jsat.2007.04.015
10.1111/add.13779
10.1111/j.1360-0443.2010.02990.x
10.1111/j.1360-0443.2005.01232.x
10.7326/M17-0865
10.1111/add.12834
10.1016/j.drugalcdep.2014.05.011
10.4103/jehp.jehp_297_13
10.1016/j.drugpo.2010.01.010
10.1097/j.pain.0000000000000837
10.1111/add.13948
10.1080/09687630701731205
10.1001/jamanetworkopen.2019.6373
10.15585/mmwr.rr6501e1
10.1016/j.drugalcdep.2008.07.012
10.1016/S2214-109X(17)30375-3
10.1159/000484239
10.1111/j.1360-0443.2005.001128.x
10.1093/cid/ciu643
10.1001/archpsyc.62.10.1157
10.1523/JNEUROSCI.4291-09.2009
10.1016/j.drugalcdep.2016.06.024
10.1016/j.drugalcdep.2014.09.782
10.1007/s00439-012-1172-4
10.1007/s11121-014-0514-y
10.2146/ajhp070392
10.1001/archpsyc.63.1.102
10.15585/mmwr.mm6614a2
10.4088/JCP.15m10386
10.1080/02791072.1996.10472486
10.1037/a0030743
10.1080/10550887.2012.694597
10.2307/352847
10.1056/NEJMoa055255
10.1016/S0140-6736(16)00161-6
10.1016/0006-8993(82)91123-4
10.2105/AJPH.2018.304673
10.1016/j.biopsych.2015.01.003
10.1016/j.jsat.2017.01.019
10.1111/j.1465-3362.2008.00042.x
10.1001/jamapsychiatry.2017.0113
10.1136/bmj.c3172
10.1111/add.12107
10.1111/add.14012
10.1038/sj.npp.1301008
10.1016/j.ejphar.2014.11.044
10.1007/s10567-007-0023-7
10.1186/s12888-017-1323-1
10.1080/08897077.2016.1261070
10.1016/j.drugpo.2016.10.014
10.1093/jurban/79.3.434
10.1177/0962280208094704
10.1080/08897077.2017.1316812
10.1016/j.drugalcdep.2009.12.001
10.1016/j.drugalcdep.2008.03.003
10.1111/j.1467-842X.2004.tb00629.x
10.1016/j.drugalcdep.2017.05.001
10.1001/archpsyc.58.5.503
10.1001/jamainternmed.2018.1052
10.2105/AJPH.2017.304187
10.1186/s13722-018-0117-1
10.1080/09595230600741024
10.1016/j.tins.2012.11.002
10.1097/00001756-200506210-00026
10.1016/S0193-953X(05)70074-5
10.1016/S0304-3959(00)00391-2
10.1046/j.1360-0443.1999.9421993.x
10.1111/j.1530-0277.2006.00273.x
10.1097/HRP.0000000000000052
10.1016/S2215-0366(19)30209-3
10.1001/jama.2016.1464
10.1136/bmj.c5475
10.1016/S0140-6736(07)60464-4
10.1177/1757913912443487
10.1016/S1550-8579(05)80042-7
10.1038/npp.2014.45
10.1016/j.pbb.2008.07.012
10.1111/add.13073
10.1111/j.1360-0443.2007.02081.x
10.1111/add.12440
10.1007/BF02246290
10.1089/cap.2019.0009
10.1111/add.12056
10.1111/add.13326
10.1038/35047086
10.2147/JPR.S138698
10.1097/ADM.0000000000000312
10.1016/j.conb.2013.03.011
10.1017/S0033291711002145
10.1001/jamainternmed.2014.5302
10.1111/dar.12092
10.1152/physrev.00005.2009
10.1001/jama.2017.9308
10.1016/j.cell.2017.10.035
10.1097/00004583-199410000-00008
10.1016/S0740-5472(00)00124-0
10.1016/j.xphs.2018.08.025
10.1016/j.pain.2010.08.036
10.1001/jamapsychiatry.2013.2216
10.1016/j.drugalcdep.2005.04.007
10.1056/NEJMra1507771
10.1016/S0140-6736(17)31959-1
10.1007/s40265-019-01154-5
10.1007/s00213-002-1027-0
10.1093/cid/ciw416
10.1152/jn.1995.73.2.568
10.1016/j.annemergmed.2019.07.014
10.1016/S0893-133X(00)00195-0
10.1155/2015/368979
10.15288/jsad.2014.75.999
10.1016/S0140-6736(18)33078-2
10.1016/j.drugalcdep.2009.11.008
10.1016/S0140-6736(19)32229-9
10.1080/02791072.2015.1014948
10.1016/S0140-6736(17)32154-2
10.1146/annurev-publhealth-031914-122957
10.1016/S0165-0173(00)00024-2
10.1192/bjp.bp.106.026112
10.1016/S0140-6736(79)91550-2
10.1136/bmj.316.7129.426
10.1001/archgenpsychiatry.2011.121
10.1007/s00213-015-4060-5
10.1016/j.biopsych.2013.08.034
10.1111/add.14053
10.1001/archpsyc.1978.01770280111012
10.1111/papr.12232
10.1056/NEJMc1610047
10.1001/jama.284.13.1689
10.3109/09687637.2015.1100587
10.1016/S2215-0366(16)00002-X
10.15585/mmwr.mm6643e1
10.1001/jamainternmed.2018.1999
10.1111/j.1360-0443.2006.01316.x
10.7326/M17-3107
10.1126/science.288.5472.1769
10.1111/add.13860
10.1093/cid/cit296
10.1016/j.jsat.2016.07.003
10.1038/nrn2515
10.1111/j.1526-4637.2010.00881.x
10.1016/j.jpain.2003.08.003
10.1097/JCP.0000000000000434
10.1080/09595230600741040
10.1111/ajt.13776
10.1046/j.1360-0443.2003.00372.x
10.1001/archpsyc.1973.01750320112017
10.1126/science.aau1184
10.1111/jasp.12434
10.1016/0006-8993(91)91724-F
10.7326/0003-4819-15-5-829
10.1016/S0740-5472(03)00125-9
10.1111/pme.12773
10.1111/j.1369-1600.2008.00142.x
10.1523/JNEUROSCI.0227-08.2008
10.1016/j.drugalcdep.2017.07.018
10.3389/fphar.2014.00253
10.1016/0166-2236(95)93946-U
10.1007/s002139900358
10.1176/ajp.156.6.842
10.1016/j.drugalcdep.2019.02.031
10.1016/j.drugalcdep.2013.10.011
10.1136/bmj.j1550
10.1038/npp.2015.258
10.1016/j.drugalcdep.2005.10.020
10.1056/NEJMsa1406143
10.1056/NEJMoa1505409
10.1016/S0306-4522(98)00652-6
10.1001/jamapsychiatry.2016.0109
10.1136/bmjopen-2013-004666
10.1001/jamanetworkopen.2018.6007
10.1016/S0140-6736(10)60742-8
10.1016/j.drugpo.2014.08.017
10.4088/JCP.v67n0211
10.1016/S0893-133X(96)00184-4
10.1001/archpsyc.1997.01830130077015
10.1016/j.jsat.2007.06.001
10.1523/JNEUROSCI.0740-06.2006
10.1016/j.biopsych.2011.05.025
10.1001/archgenpsychiatry.2012.1a
10.1111/j.1360-0443.2007.01914.x
10.1016/0014-2999(92)90706-A
10.1080/02791072.2003.10400007
10.1007/s11904-018-0396-x
10.1038/255159b0
10.1136/bmj.e5945
10.1038/mp.2015.102
10.1002/car.1100
10.1016/j.drugalcdep.2017.09.006
10.1016/j.jsat.2017.02.011
10.1016/S0140-6736(78)90699-2
10.15585/mmwr.mm6533a2
10.1503/cmaj.170363
10.1016/S2468-2667(18)30232-9
10.1136/bmj.327.7410.310
10.1016/j.drugalcdep.2014.10.012
10.1177/002204268601600106
10.1001/archgenpsychiatry.2008.509
10.3109/00952990.2014.910519
10.1007/978-1-4757-0145-6_1
10.1186/s12913-019-4642-8
10.1111/j.1369-1600.2012.00445.x
10.1056/NEJMp1710014
10.1016/S0140-6736(03)12600-1
10.1111/j.1360-0443.2012.04001.x
10.1016/S0140-6736(11)61674-7
10.1093/ije/dyt243
10.1016/j.jsat.2015.01.009
10.1016/S0140-6736(16)00619-X
10.7326/0003-4819-119-1-199307010-00004
10.1016/S0140-6736(14)62338-2
10.1056/NEJMoa0810635
10.1111/1467-9566.12467
10.1177/0272989X16683928
10.1016/j.pain.2006.10.004
10.1111/j.1360-0443.2009.02754.x
10.1126/science.2903550
10.1093/aje/kwh306
10.4088/JCP.v66n0504
10.1016/j.drugalcdep.2010.11.032
10.1016/j.addbeh.2006.07.013
10.1016/j.jhep.2016.02.007
10.1523/JNEUROSCI.22-12-05100.2002
10.1056/NEJM200011023431802
10.1016/j.drugpo.2011.09.001
10.1016/j.drugalcdep.2005.11.008
10.1016/j.drugalcdep.2007.04.006
10.1111/add.14188
10.1016/j.drugalcdep.2013.01.010
10.1016/S2215-0366(15)00366-1
10.1016/j.jsat.2005.02.007
10.1111/add.13224
10.1016/j.drugpo.2015.09.009
10.1126/science.278.5335.52
10.1016/S0896-6273(00)80110-5
10.1001/jama.2016.9382
10.1038/nrn1431
10.1111/j.1360-0443.2007.01971.x
10.1056/NEJMra1508490
10.1016/j.ejphar.2015.03.081
10.1097/00000542-200008000-00019
10.1007/BF02532387
10.1046/j.1360-0443.1999.9479612.x
10.1016/j.chiabu.2008.09.009
10.1615/CritRevNeurobiol.v14.i1.30
10.1503/cmaj.060863
10.1016/j.drugalcdep.2016.06.006
10.1002/syn.890140210
10.1126/science.841320
10.2471/BLT.12.108282
10.1176/appi.ajp.159.10.1642
10.1038/npp.2009.110
10.1177/0193841X9802200404
10.1186/s12913-018-2830-6
10.1111/add.12536
10.1016/S0140-6736(17)32812-X
10.1056/NEJMra025411
10.1017/S0033291798006667
10.1192/bjp.bp.114.149195
10.1111/add.13453
10.3389/fnins.2015.00466
10.1353/eca.2017.0005
10.1046/j.1460-9568.1998.00083.x
10.1111/adb.12120
10.1016/j.jsat.2004.09.006
10.1159/000444755
10.1016/S0140-6736(10)60349-2
10.1016/S2215-0366(19)30097-5
10.1146/annurev-pharmtox-010716-104615
10.1016/0306-4603(90)90036-W
10.1172/JCI60390
10.1523/JNEUROSCI.1978-13.2015
10.1016/j.drugalcdep.2019.107563
10.1111/add.13783
10.1016/j.jsat.2004.10.013
10.1371/journal.pone.0003351
10.1111/j.1460-9568.2010.07590.x
10.1111/j.1360-0443.2006.01603.x
10.1097/00001756-200301200-00001
10.1016/j.drugalcdep.2013.01.007
10.1016/j.drugalcdep.2016.11.029
10.1111/add.12333
10.1186/1744-8069-9-45
10.1016/S0140-6736(96)90409-2
10.1038/nrg1635
10.1046/j.1360-0443.2003.00354.x
10.1176/ajp.133.1.37
10.1111/j.1360-0443.2011.03602.x
10.1093/bjc/azq038
10.15585/mmwr.mm655051e1
10.1097/ADM.0b013e3181d41ddb
10.1016/S0140-6736(98)05356-2
10.1177/1060028015581848
10.1097/ADM.0000000000000035
10.1111/j.1360-0443.2012.04066.x
10.1080/10550887.2011.581985
10.1016/j.drugalcdep.2015.10.009
10.1037/0033-2909.112.1.64
10.1002/pds.3901
10.1093/oso/9780198818014.001.0001
10.1542/peds.94.3.368
10.1176/appi.books.9780890425596
10.1017/CBO9780511543883
10.1007/978-1-4684-3426-2
10.3109/15360288.2016.1173761
10.1016/B978-0-12-385870-2.00041-X
ContentType Journal Article
Copyright Springer Nature Limited 2020
2020© Springer Nature Limited 2020
Springer Nature Limited 2020.
Copyright_xml – notice: Springer Nature Limited 2020
– notice: 2020© Springer Nature Limited 2020
– notice: Springer Nature Limited 2020.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
DOI 10.1038/s41572-019-0137-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE

MEDLINE - Academic
ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 2056-676X
ExternalDocumentID 31919349
10_1038_s41572_019_0137_5
Genre Review
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: P20 GM125507
– fundername: Department of Health
  grantid: RP-PG-0616-20008
– fundername: Department of Health
  grantid: 12/136/105
GroupedDBID 0R~
53G
7X7
88I
8FI
8FJ
AAEEF
AARCD
AAWYQ
AAYZH
AAZLF
ABJNI
ABLJU
ABUWG
ACGFS
ACMJI
ADBBV
AFKRA
AFSHS
AGAYW
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARMCB
AXYYD
AZQEC
BENPR
BKKNO
BPHCQ
BVXVI
CCPQU
DWQXO
EBS
FQGFK
FSGXE
FYUFA
FZEXT
GNUQQ
HCIFZ
HMCUK
LGEZI
LOTEE
M2P
NADUK
NNMJJ
NXXTH
PQQKQ
PROAC
R9-
RNR
RNT
SHXYY
SIXXV
SNYQT
SOJ
TAOOD
TBHMF
TDRGL
TSG
UKHRP
AAYXX
ABFSG
ACMFV
ACSTC
AEZWR
AFANA
AFHIU
AHWEU
AIXLP
ATHPR
BBNVY
BHPHI
CITATION
M7P
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PQGLB
3V.
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c400t-1c80c83b921fb5757e7e1e0e24a5961543ba77dd9773ca8f686bf71e04e9f3d43
IEDL.DBID 7X7
ISSN 2056-676X
IngestDate Fri Jul 11 05:22:03 EDT 2025
Sat Aug 23 14:05:59 EDT 2025
Wed Jul 16 16:37:42 EDT 2025
Mon Jul 21 06:05:06 EDT 2025
Tue Jul 01 02:52:21 EDT 2025
Thu Apr 24 22:58:48 EDT 2025
Fri Feb 21 02:37:58 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c400t-1c80c83b921fb5757e7e1e0e24a5961543ba77dd9773ca8f686bf71e04e9f3d43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
PMID 31919349
PQID 2342379410
PQPubID 2069613
ParticipantIDs proquest_miscellaneous_2336246726
proquest_journals_3103047271
proquest_journals_2342379410
pubmed_primary_31919349
crossref_primary_10_1038_s41572_019_0137_5
crossref_citationtrail_10_1038_s41572_019_0137_5
springer_journals_10_1038_s41572_019_0137_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-09
PublicationDateYYYYMMDD 2020-01-09
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-09
  day: 09
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature reviews. Disease primers
PublicationTitleAbbrev Nat Rev Dis Primers
PublicationTitleAlternate Nat Rev Dis Primers
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Bickel (CR274) 1988; 247
Aspinall (CR236) 2014; 43
Nelson (CR35) 2014; 19
Bossert, Busch, Gray (CR130) 2005; 16
Chase, Eickhoff, Laird, Hogarth (CR138) 2011; 70
Milloy, Kerr, Tyndall, Montaner, Wood (CR243) 2008; 3
Walsh (CR284) 1995; 119
Low (CR218) 2016; 63
Rhodes, Wilson, Robinson, Hayden, Asbridge (CR199) 2019; 19
Lynskey, Fergusson (CR60) 1995; 23
Strain, Stitzer, Liebson, Bigelow (CR276) 1993; 119
Krupitsky (CR308) 2012; 69
Bester, Menendez, Besson, Bernard (CR172) 1995; 73
Rich, Bia, Altice, Feinberg (CR251) 2018; 15
Chartoff, Mavrikaki (CR154) 2015; 9
Somerville (CR79) 2017; 66
Dowell, Haegerich, Chou (CR41) 2016; 65
Epstein (CR137) 2009; 66
Campbell (CR59) 2015; 16
Degenhardt (CR7) 2011; 117
CR174
Strang (CR238) 2008; 15
Dowell (CR348) 2017; 318
Kakko, Svanborg, Kreek, Heilig (CR258) 2003; 361
CR291
O’Donnell, Halpin, Mattson, Goldberger, Gladden (CR75) 2017; 66
Raehal, Bohn (CR105) 2014; 219
Meier (CR255) 2014; 40
Laulin, Celerier, Larcher, Le Moal, Simonnet (CR99) 1999; 89
Brady, Randall (CR153) 1999; 22
Kelly, Humphreys, Ferri (CR329) 2019; 9
De Leon, Hawke, Jainchill, Melnick (CR331) 2000; 19
Tsui (CR162) 2016; 166
Amato, Minozzi, Davoli, Vecchi (CR317) 2011; 5
Rossetti, Hmaidan, Gessa (CR114) 1992; 221
CR152
CR273
Rosenthal (CR289) 2016; 316
Saha (CR34) 2016; 77
Nutt, King, Saulsbury, Blakemore (CR18) 2007; 369
Pierce, Bird, Hickman, Millar (CR177) 2015; 146
O’Brien, McLellan (CR223) 1996; 347
Marsch (CR354) 2005; 62
CR386
CR387
Day, Degenhardt, Hall (CR187) 2006; 25
Kreek (CR132) 1996; 1
Strang (CR302) 2015; 207
Connock (CR219) 2007; 11
Zijlstra, Veltman, Booij, van den Brink, Franken (CR116) 2009; 99
Kuhn, Gallinat (CR139) 2011; 33
Amato, Minozzi, Davoli, Vecchi (CR263) 2011; 9
Stone (CR230) 2017; 112
Volkow (CR83) 2016; 352
Degenhardt (CR225) 2014; 109
Jensen (CR148) 2016; 2
Goldstein, Volkow (CR89) 2002; 159
Panebianco, Gallupe, Carrington, Colozzi (CR381) 2016; 27
Stringer, Welsh, Tommasello (CR281) 2009; 66
Larney (CR228) 2014; 4
Seaman, Brettle, Gore (CR260) 1998; 316
Garner, Scott, Dennis, Funk (CR371) 2014; 47
Gossop (CR264) 1990; 15
White (CR368) 2005; 23
Sordo (CR22) 2017; 357
CR250
Gossop, Johns, Green (CR267) 1986; 293
Muller, Skurtveit, Clausen (CR382) 2017; 180
Volkow, Hampson, Baler (CR124) 2017; 57
Vijay (CR158) 2016; 6
CR246
Wang (CR115) 1997; 16
Haegerich, Jones, Cote, Robinson, Ross (CR200) 2019; 204
Haffajee, Lin, Bohnert, Goldstick (CR193) 2019; 2
Fischer, Pang, Tyndall (CR350) 2019; 4
Feng, Zhu, Zhou (CR278) 2017; 10
Rubin (CR17) 2017; 318
Nestler, Malenka (CR142) 2004; 290
Hser (CR288) 2016; 111
Frenk, Porter, Paulozzi (CR12) 2015; 189
Martins (CR71) 2012; 42
Gelernter (CR149) 2014; 76
Lutz, Kieffer (CR92) 2013; 36
Ballantyne, Mao (CR191) 2003; 349
Dennis, Scott, Funk, Foss (CR339) 2005; 28
Konkoly Thege (CR68) 2017; 17
Whitfield (CR121) 2015; 35
Dowell, Haegerich, Chou (CR36) 2016; 65
MacArthur (CR214) 2012; 345
Dunn (CR306) 2013; 21
Compton, Volkow (CR48) 2006; 83
Al Achkar (CR197) 2018; 18
Brooner, King, Kidorf, Schmidt, Bigelow (CR253) 1997; 54
Sadeghi, Davaridolatabadi, Rahmani, Ghodousi, Ziaeirad (CR358) 2017; 6
CR221
CR101
Nasser (CR290) 2016; 36
Nielsen (CR147) 2015; 15
Stinus, Caille, Koob (CR134) 2000; 149
Kelly, Greene (CR322) 2013; 133
Gaspari (CR103) 2014; 39
Kariisa, Scholl, Wilson, Seth, Hoots (CR204) 2019; 68
Gold, Redmond, Kleber (CR271) 1978; 1
Carlezon, Nestler, Neve (CR123) 2000; 14
CR313
Humphreys, Lembke (CR369) 2014; 33
CR314
CR312
Mayet, Farrell, Ferri, Amato, Davoli (CR360) 2005; 25
Koob, Le Moal (CR90) 1997; 278
CR315
CR316
Butt, Chou, Browne (CR67) 2011; 20
Hickman (CR234) 2018; 113
Roxburgh (CR351) 2017; 179
Blanken, Hendriks, van Ree, van den Brink (CR303) 2010; 105
Foxcroft, Tsertsvadze (CR182) 2012; 132
White (CR325) 2007; 33
Doverty (CR161) 2001; 90
CR324
Termorshuizen (CR28) 2005; 79
Jasinski, Pevnick, Griffith (CR282) 1978; 35
CR209
Volkow, McLellan (CR108) 2016; 374
CR207
CR208
Marsden (CR224) 2017; 112
Platt (CR215) 2018; 113
Guignard (CR98) 2000; 93
Beck (CR294) 2014; 109
Neale (CR377) 2016; 165
Schmid (CR107) 2017; 171
Davis, Carr (CR44) 2017; 38
Donny, Brasser, Bigelow, Stitzer, Walsh (CR277) 2005; 100
Fiellin (CR257) 2014; 174
Case, Deaton (CR353) 2017; 2017
Compton, Jones, Baldwin (CR206) 2016; 374
Petrar (CR244) 2007; 32
Dasgupta, Beletsky, Ciccarone (CR72) 2018; 108
Zhang, Friedmann, Gerstein (CR361) 2003; 98
Ren, Whittard, Higuera-Matas, Morris, Hurd (CR163) 2009; 29
Larochelle (CR310) 2018; 169
Hawk, D’Onofrio (CR334) 2018; 13
Barocas (CR5) 2018; 108
Levine (CR362) 2015; 54
Reuter, Kleiman (CR185) 1986; 7
Mathers (CR212) 2013; 91
Fields (CR104) 2004; 5
Jalal (CR186) 2018; 361
Scott, Foss, Dennis (CR343) 2005; 28
Paulozzi, Mack, Hockenberry (CR39) 2014; 63
Carcoba, Contreras, Cepeda-Benito, Meagher (CR164) 2011; 30
Neugebauer (CR170) 2007; 127
Matson, Hobson, Abdel-Rasoul, Bonny (CR364) 2014; 8
Stewart, Wise (CR127) 1992; 108
Simpson, Joe, Lehman, Sells (CR340) 1986; 16
Gladden, Martinez, Seth (CR76) 2016; 65
Oviedo-Joekes (CR301) 2009; 361
Gibson, Randall, Degenhardt (CR178) 2011; 106
Sweeting, De Angelis, Ades, Hickman (CR25) 2009; 18
Wesson, Ling (CR265) 2003; 35
CR3
CR6
Kalivas (CR128) 2009; 10
Krupitsky (CR307) 2011; 377
Koob, Bloom (CR117) 1988; 242
Hadland, Cerda, Li, Krieger, Marshall (CR42) 2018; 178
Kimber, Larney, Hickman, Randall, Degenhardt (CR24) 2015; 2
Hser, Evans, Grella, Ling, Anglin (CR342) 2015; 23
Hadland, Rivera-Aguirre, Marshall, Cerda (CR43) 2019; 2
Hser (CR363) 2014; 109
Neale (CR378) 2015; 23
Squeglia, Fadus, McClure, Tomko, Gray (CR283) 2019
Ward, Hall, Mattick (CR355) 1999; 353
Petry, Stinson, Grant (CR254) 2005; 66
Morgan, Schackman, Weinstein, Walley, Linas (CR311) 2019; 200
Rosado, Walsh, Bigelow, Strain (CR286) 2007; 90
Moyo (CR198) 2017; 112
Strang, McDonald, Campbell, Degenhardt, Nielsen, Ritter, Dale (CR332) 2019; 79
Laulin, Larcher, Celerier, Le Moal, Simonnet (CR165) 1998; 10
Georgie, Sean, Deborah, Matthew, Rona (CR184) 2016; 111
Gisev (CR220) 2015; 110
Lofwall (CR292) 2018; 178
Nestler (CR140) 1996; 16
Rich (CR227) 2015; 386
Greenwell, Walker, Cottone, Zorrilla, Koob (CR119) 2009; 91
Stockings (CR183) 2016
Cepeda (CR232) 2018; 5
Walsh, Strain, Bigelow (CR269) 2003; 98
Yiannakopoulou (CR145) 2015; 2015
Mucha, van der Kooy, O’Shaughnessy, Bucenieks (CR96) 1982; 243
Stewart, Henderson, Hobbs, Ridout, Knuiman (CR335) 2004; 28
Nosyk (CR357) 2015; 157
Sigmon (CR320) 2016; 375
Mattick, Breen, Kimber, Davoli (CR211) 2009; 8
Kreek (CR19) 2012; 122
Fraser (CR231) 2018; 113
Meemken, Hanhoff, Tseng, Christensen, Gillessen (CR280) 2015; 49
De Angelis, Hickman, Yang (CR26) 2004; 160
Kenny, Chen, Kitamura, Markou, Koob (CR136) 2006; 26
Martin (CR100) 1973; 28
Volpe, Xu, Sahajwalla, Younis, Patel (CR279) 2018; 107
Zinberg, Jacobson (CR20) 1976; 133
Suryaprasad (CR81) 2014; 59
Malekinejad, Vazirian (CR10) 2012; 23
Darke, Torok, Ross (CR69) 2017; 47
Gordon (CR337) 2014; 142
Donny, Walsh, Bigelow, Eissenberg, Stitzer (CR275) 2002; 161
Godfrey, Stewart, Gossop (CR217) 2004; 99
Hancock (CR146) 2015; 78
Newman, Whitehill (CR259) 1979; 2
Chen (CR95) 2006; 31
Laudet (CR373) 2011; 6
Feelemyer, Jarlais, Arasteh, Phillips, Hagan (CR372) 2014; 134
Strang (CR300) 2010; 375
Gjersing, Bretteville-Jensen (CR344) 2018; 113
Wood, Tyndall, Montaner, Kerr (CR245) 2006; 175
Barnett, Gray, Zink, Jena (CR203) 2017; 377
Dowell, Haegerich, Chou (CR37) 2016; 315
Mehta (CR31) 2012; 107
Degenhardt, Larney, Randall, Burns, Hall (CR346) 2014; 109
Luchenski (CR189) 2018; 391
Lee (CR336) 2016; 374
Khademi (CR9) 2012; 344
Volkow (CR125) 1993; 14
McNally, Akil (CR173) 2002; 112
McLellan, Lewis, O’Brien, Kleber (CR222) 2000; 284
Degenhardt (CR73) 2010; 108
Simonnet, Rivat (CR159) 2003; 14
Shah, Galai, Celentano, Vlahov, Strathdee (CR29) 2006; 83
Fischer, Russell, Murphy, Kurdyak (CR77) 2015; 24
Cahill (CR102) 2014; 5
Greenwell (CR118) 2009; 14
Bossert (CR129) 2016; 233
Nguyen Bich, Korthuis, Nguyen Thu, Van Dinh, Le Minh (CR252) 2016; 69
Katz, El-Gabalawy, Keyes, Martins, Sareen (CR62) 2013; 132
Carroll, Marshall, Rich, Green (CR78) 2017; 46
Merrall (CR23) 2010; 105
Merrall, Bird, Hutchinson (CR262) 2013; 108
Degenhardt (CR86) 2017; 5
Maloney, Degenhardt, Darke, Mattick, Nelson (CR85) 2007; 102
Martin (CR235) 2016; 65
Le Merrer, Becker, Befort, Kieffer (CR97) 2009; 89
Minozzi (CR305) 2011; 16
Latowsky (CR109) 1996; 28
Berterame (CR190) 2016; 87
Rudd, Aleshire, Zibbell, Matthew Gladden (CR74) 2016; 16
Zubieta, Dannals, Frost (CR156) 1999; 156
Shurman, Koob, Gutstein (CR169) 2010; 11
Nestler (CR383) 2005; 8
Fu, Neugebauer (CR166) 2008; 28
Larney, Peacock, Mathers, Hickman, Degenhardt (CR88) 2017; 171
Fiellin (CR319) 2006; 355
Bohn, Gainetdinov, Lin, Lefkowitz, Caron (CR106) 2000; 408
Darke (CR347) 2015; 76
Razani (CR11) 2007; 102
Kimber (CR30) 2010; 341
Daniel (CR54) 2009; 28
Knudsen, Abraham, Roman (CR359) 2011; 5
Dart (CR13) 2015; 372
Zibbell (CR82) 2015; 64
Koob (CR112) 2015; 753
Cornish, Macleod, Strang, Vickerman, Hickman (CR233) 2010; 341
Platt (CR216) 2017; 9
Degenhardt (CR33) 2010; 376
Kertesz (CR205) 2017; 38
Vos (CR8) 2017; 390
Robertson (CR297) 2006; 101
Nelson (CR150) 2016; 21
Burns (CR365) 2015; 110
White (CR326) 2012; 31
Ford, Rigg (CR50) 2015; 16
Compton, Athanasos, Elashoff (CR160) 2003; 4
Pirastu (CR126) 2006; 83
Levran, Yuferov, Kreek (CR144) 2012; 131
Park (CR120) 2015; 20
Eder (CR293) 2005; 100
Himmelsbach (CR266) 1941; 15
van den Brink (CR298) 2003; 327
Shaham, Erb, Stewart (CR131) 2000; 33
Chavkin, Koob (CR122) 2016; 41
Lee (CR309) 2018; 391
Taylor (CR229) 2013; 108
Hser, Grella, Chou, Douglas Anglin (CR379) 1998; 22
Flynn, Joe, Broome, Simpson, Brown (CR380) 2003; 25
White, Irvine (CR176) 1999; 94
Blanco, Volkow (CR1) 2019; 393
Degenhardt (CR38) 2019; 394
Mansour, Fox, Akil, Watson (CR91) 1995; 18
Humphreys, Moos (CR323) 2007; 31
Martins (CR16) 2017; 74
Macleod (CR66) 2013; 108
Cousins, Crevecoeur-MacPhail, Kim, Rawson (CR366) 2018; 85
Lee, Ho (CR151) 2013; 9
Conway, Compton, Stinson, Grant (CR256) 2006; 67
Stoller, Bigelow, Walsh, Strain (CR285) 2001; 154
Krebs (CR341) 2017; 37
Felix, Portugal (CR248) 2017; 39
Strang (CR237) 1999; 94
CR47
Needle, Su, Doherty (CR58) 1990; 52
CR46
Darke (CR70) 2013; 108
Goldman, Oroszi, Ducci (CR143) 2005; 6
CR45
Farrell, Marsden (CR261) 2008; 103
De Maeyer, Vanderplasschen, Broekaert (C
S Berterame (137_CR190) 2016; 87
J Neale (137_CR378) 2015; 23
SH Mehta (137_CR31) 2012; 107
SM Frenk (137_CR12) 2015; 189
C Godfrey (137_CR217) 2004; 99
M Farrell (137_CR261) 2008; 103
A Mansour (137_CR91) 1995; 18
KP Conway (137_CR256) 2006; 67
KM Raehal (137_CR105) 2014; 219
EJ Nestler (137_CR140) 1996; 16
GJ MacArthur (137_CR214) 2012; 345
YI Hser (137_CR338) 1997; 14
SE Hadland (137_CR43) 2019; 2
ND Volkow (137_CR124) 2017; 57
L Degenhardt (137_CR346) 2014; 109
E Stockings (137_CR183) 2016
J Kakko (137_CR258) 2003; 361
CS Davis (137_CR44) 2017; 38
K Humphreys (137_CR323) 2007; 31
RP Mattick (137_CR211) 2009; 8
Y-I Hser (137_CR379) 1998; 22
NJ Somerville (137_CR79) 2017; 66
RK Brooner (137_CR253) 1997; 54
W van den Brink (137_CR298) 2003; 327
EC Donny (137_CR277) 2005; 100
JJ Carroll (137_CR78) 2017; 46
R McDonald (137_CR239) 2017
L Strada (137_CR374) 2017; 23
137_CR65
Z Wiesenfeld-Hallin (137_CR155) 2005; 2
M Amin-Esmaeili (137_CR49) 2016; 111
S Petrar (137_CR244) 2007; 32
P Reuter (137_CR185) 1986; 7
S Mayet (137_CR360) 2005; 25
137_CR64
LM Stewart (137_CR335) 2004; 28
J Hawkins (137_CR53) 1992; 112
L Townsend (137_CR61) 2007; 10
G Simonnet (137_CR159) 2003; 14
JP Laulin (137_CR165) 1998; 10
J Ward (137_CR355) 1999; 353
MR Larochelle (137_CR310) 2018; 169
C Day (137_CR187) 2006; 25
137_CR94
F Termorshuizen (137_CR28) 2005; 79
EJ Aspinall (137_CR236) 2014; 43
C Katz (137_CR62) 2013; 132
137_CR93
D Goldman (137_CR143) 2005; 6
THE WHOQOL GROUP (137_CR375) 1998; 28
D Dowell (137_CR36) 2016; 65
RP Schwartz (137_CR321) 2006; 63
A Kolodny (137_CR40) 2015; 36
L Stinus (137_CR134) 2000; 149
D Dowell (137_CR348) 2017; 318
ZL Rossetti (137_CR114) 1992; 221
MT Lynskey (137_CR60) 1995; 23
137_CR84
GJ Wang (137_CR115) 1997; 16
137_CR80
JR Morgan (137_CR311) 2019; 200
CP O’Brien (137_CR110) 1977; 195
M Meini (137_CR295) 2015
B Nosyk (137_CR357) 2015; 157
WL White (137_CR368) 2005; 23
BM Mathers (137_CR212) 2013; 91
GF Koob (137_CR167) 2010; 35
J Gelernter (137_CR149) 2014; 76
JC Ballantyne (137_CR191) 2003; 349
E Oviedo-Joekes (137_CR304) 2016; 73
J Stewart (137_CR127) 1992; 108
JW Busse (137_CR196) 2017; 189
SC Matson (137_CR364) 2014; 8
YI Hser (137_CR345) 2017; 11
AJ Low (137_CR218) 2016; 63
J O’Donnell (137_CR75) 2017; 66
AB Laudet (137_CR373) 2011; 6
N Dasgupta (137_CR72) 2018; 108
YI Hser (137_CR342) 2015; 23
J Marsden (137_CR224) 2017; 112
JW Bray (137_CR370) 2017; 76
JE Zibbell (137_CR82) 2015; 64
L Amato (137_CR210) 2005; 28
M Connock (137_CR219) 2007; 11
R Cornish (137_CR233) 2010; 341
T Beck (137_CR294) 2014; 109
L Platt (137_CR216) 2017; 9
C Blanco (137_CR1) 2019; 393
U Verthein (137_CR296) 2005; 80
JF Kelly (137_CR329) 2019; 9
KN Gracy (137_CR135) 2001; 24
L Gjersing (137_CR344) 2018; 113
EC Donny (137_CR275) 2002; 161
M Gossop (137_CR267) 1986; 293
J Shurman (137_CR169) 2010; 11
H Bester (137_CR172) 1995; 73
R Pirastu (137_CR126) 2006; 83
S Larney (137_CR228) 2014; 4
CW Lee (137_CR151) 2013; 9
GF Koob (137_CR112) 2015; 753
A Gibson (137_CR178) 2011; 106
GF Koob (137_CR117) 1988; 242
L Heimer (137_CR111) 1991; 295
M Kariisa (137_CR204) 2019; 68
C Chavkin (137_CR122) 2016; 41
EJ Nestler (137_CR142) 2004; 290
RF Mucha (137_CR96) 1982; 243
B Guignard (137_CR98) 2000; 93
M Hickman (137_CR234) 2018; 113
HW Chase (137_CR138) 2011; 70
J Strang (137_CR237) 1999; 94
LJ Paulozzi (137_CR39) 2014; 63
V Neugebauer (137_CR170) 2007; 127
Y Ren (137_CR163) 2009; 29
F Zijlstra (137_CR116) 2009; 99
TM Haegerich (137_CR200) 2019; 204
A Roxburgh (137_CR351) 2017; 179
AF Nasser (137_CR290) 2016; 36
DA Fiellin (137_CR319) 2006; 355
DH Epstein (137_CR137) 2009; 66
L Degenhardt (137_CR87) 2016; 16
D Dowell (137_CR37) 2016; 315
JF Kelly (137_CR322) 2013; 133
WA Carlezon Jr. (137_CR123) 2000; 14
M Pierce (137_CR177) 2015; 146
KM Rich (137_CR251) 2018; 15
S Darke (137_CR70) 2013; 108
PM Flynn (137_CR380) 2003; 25
JM Georgie (137_CR184) 2016; 111
RA Rudd (137_CR74) 2016; 16
SL Walsh (137_CR269) 2003; 98
LM Bohn (137_CR106) 2000; 408
CK Himmelsbach (137_CR266) 1941; 15
Y Shaham (137_CR131) 2000; 33
MS Gordon (137_CR337) 2014; 142
J Csete (137_CR179) 2016; 387
L Degenhardt (137_CR73) 2010; 108
G Melnick (137_CR330) 2001; 27
M Malekinejad (137_CR10) 2012; 23
SC Sigmon (137_CR272) 2013; 70
WK Bickel (137_CR274) 1988; 247
JK Zubieta (137_CR157) 2002; 22
EH Chartoff (137_CR154) 2015; 9
E Krebs (137_CR341) 2017; 37
SC Sigmon (137_CR320) 2016; 375
SE Hadland (137_CR42) 2018; 178
J Marsden (137_CR4) 2019; 6
NG Shah (137_CR29) 2006; 83
NE Zinberg (137_CR20) 1976; 133
BR Garner (137_CR371) 2014; 47
PE Park (137_CR120) 2015; 20
SJ Cousins (137_CR366) 2018; 85
K Stoller (137_CR285) 2001; 154
MJ Sweeting (137_CR25) 2009; 18
RD Weiss (137_CR318) 2011
S Darke (137_CR347) 2015; 76
M Gold (137_CR271) 1978; 1
SG Kertesz (137_CR205) 2017; 38
JM White (137_CR176) 1999; 94
SG Mitchell (137_CR356) 2015; 47
MJ Kreek (137_CR132) 1996; 1
SA Chen (137_CR95) 2006; 31
CE Hughes (137_CR247) 2010; 50
D De Angelis (137_CR26) 2004; 160
RH Needle (137_CR58) 1990; 52
PE Lutz (137_CR92) 2013; 36
ND Volkow (137_CR108) 2016; 374
EC Nelson (137_CR150) 2016; 21
L A Lin (137_CR201) 2017; 158
JM Bossert (137_CR129) 2016; 233
A Case (137_CR353) 2017; 2017
L Degenhardt (137_CR33) 2010; 376
137_CR51
NM Petry (137_CR254) 2005; 66
B Konkoly Thege (137_CR68) 2017; 17
C Potier (137_CR242) 2014; 145
E Ravndal (137_CR333) 2010; 108
N Razani (137_CR11) 2007; 102
DM Fergusson (137_CR52) 2008; 96
E Wood (137_CR245) 2006; 175
RG Newman (137_CR259) 1979; 2
TD Saha (137_CR34) 2016; 77
137_CR47
JZ Daniel (137_CR54) 2009; 28
137_CR45
137_CR46
L A Kaskutas (137_CR367) 2014; 75
MA Irvine (137_CR202) 2019; 114
H Khademi (137_CR9) 2012; 344
L Sordo (137_CR22) 2017; 357
G Campbell (137_CR59) 2015; 16
137_CR315
137_CR316
CP O’Brien (137_CR223) 1996; 347
137_CR313
MR Lofwall (137_CR292) 2018; 178
137_CR314
137_CR312
AT McLellan (137_CR222) 2000; 284
SS Martins (137_CR16) 2017; 74
HO Collier (137_CR141) 1975; 255
J Strang (137_CR238) 2008; 15
S Kuhn (137_CR139) 2011; 33
CK Scott (137_CR343) 2005; 28
YI Hser (137_CR21) 2001; 58
L Amato (137_CR263) 2011; 9
G Ridge (137_CR270) 2009; 37
YI Hser (137_CR32) 2007; 31
H Fields (137_CR104) 2004; 5
J Le Merrer (137_CR97) 2009; 89
F Faggiano (137_CR181) 2014; 12
137_CR324
JA Barocas (137_CR5) 2018; 108
T Vos (137_CR8) 2017; 390
M Latowsky (137_CR109) 1996; 28
EC Strain (137_CR276) 1993; 119
H Eder (137_CR293) 2005; 100
MJ Milloy (137_CR243) 2008; 3
S Larney (137_CR88) 2017; 171
CM Cahill (137_CR102) 2014; 5
JD Lee (137_CR309) 2018; 391
O Levran (137_CR144) 2012; 131
WL White (137_CR325) 2007; 33
TN Greenwell (137_CR119) 2009; 91
MJ Kreek (137_CR133) 1996; 21
DA Volpe (137_CR279) 2018; 107
L Meemken (137_CR280) 2015; 49
D Nutt (137_CR18) 2007; 369
S Minozzi (137_CR305) 2011; 16
WL White (137_CR326) 2012; 31
JA Ford (137_CR50) 2015; 16
TW Whitfield Jr (137_CR121) 2015; 35
MJ Kreek (137_CR19) 2012; 122
GF Koob (137_CR168) 2001; 24
WM Compton (137_CR48) 2006; 83
L Platt (137_CR215) 2018; 113
M Al Achkar (137_CR197) 2018; 18
J Kimber (137_CR30) 2010; 341
L Degenhardt (137_CR7) 2011; 117
J Strang (137_CR302) 2015; 207
L Amato (137_CR317) 2011; 5
L Burns (137_CR365) 2015; 110
EL Merrall (137_CR23) 2010; 105
JA Cepeda (137_CR232) 2018; 5
N Gisev (137_CR220) 2015; 110
C Haasen (137_CR299) 2007; 191
N Krawczyk (137_CR192) 2019
SR Seaman (137_CR260) 1998; 316
DM Fergusson (137_CR56) 1994; 33
MD Sullivan (137_CR63) 2010; 151
J Kimber (137_CR24) 2015; 2
J De Maeyer (137_CR376) 2010; 21
KP Jensen (137_CR148) 2016; 2
EC Nelson (137_CR35) 2014; 19
WR Martin (137_CR100) 1973; 28
DB Hancock (137_CR146) 2015; 78
YI Hser (137_CR288) 2016; 111
GP McNally (137_CR173) 2002; 112
137_CR246
EL Merrall (137_CR262) 2013; 108
K Humphreys (137_CR369) 2014; 33
RA Rudd (137_CR349) 2016; 65
E Krupitsky (137_CR307) 2011; 377
J Strang (137_CR2) 2012; 379
L Degenhardt (137_CR225) 2014; 109
E Krupitsky (137_CR308) 2012; 69
R Gladden (137_CR76) 2016; 65
J Kimber (137_CR352) 2019; 6
R Rubin (137_CR17) 2017; 318
JD Rich (137_CR227) 2015; 386
RE Johnson (137_CR287) 2000; 343
J Gfroerer (137_CR27) 1992; 87
J Stone (137_CR230) 2017; 112
A Taylor (137_CR229) 2013; 108
137_CR209
137_CR207
137_CR208
E Drucker (137_CR180) 2002; 79
JR Robertson (137_CR297) 2006; 101
DD Simpson (137_CR340) 1986; 16
L A Marsch (137_CR354) 2005; 62
137_CR221
137_CR101
J Stringer (137_CR281) 2009; 66
E Pothos (137_CR113) 1991; 566
137_CR3
R McDonald (137_CR240) 2016; 111
ML Barnett (137_CR203) 2017; 377
137_CR6
J Neale (137_CR377) 2016; 165
A Meier (137_CR255) 2014; 40
DA Cohen (137_CR55) 1994; 94
HK Knudsen (137_CR359) 2011; 5
E Yiannakopoulou (137_CR145) 2015; 2015
KE Dunn (137_CR306) 2013; 21
A Vijay (137_CR158) 2016; 6
EJ Nestler (137_CR383) 2005; 8
B Fischer (137_CR77) 2015; 24
S Felix (137_CR248) 2017; 39
D Panebianco (137_CR381) 2016; 27
137_CR152
137_CR273
ND Volkow (137_CR125) 1993; 14
CL Schmid (137_CR107) 2017; 171
P Blanken (137_CR303) 2010; 105
P Compton (137_CR160) 2003; 4
DD Price (137_CR171) 2000; 288
S Darke (137_CR69) 2017; 47
N Sadeghi (137_CR358) 2017; 6
DR Foxcroft (137_CR182) 2012; 132
S Gaspari (137_CR103) 2014; 39
RN Rosenthal (137_CR289) 2016; 316
JI Tsui (137_CR162) 2016; 166
John Strang (137_CR332) 2019; 79
RL Haffajee (137_CR193) 2019; 2
NK Martin (137_CR385) 2013; 57
J Strang (137_CR300) 2010; 375
JD Lee (137_CR336) 2016; 374
AE Muller (137_CR382) 2017; 180
K Hawk (137_CR334) 2018; 13
NK Martin (137_CR235) 2016; 65
CM Jones (137_CR15) 2013; 132
TN Greenwell (137_CR118) 2009; 14
E Oviedo-Joekes (137_CR301) 2009; 361
D Nguyen Bich (137_CR252) 2016; 69
RZ Goldstein (137_CR89) 2002; 159
137_CR250
Z Zhang (137_CR361) 2003; 98
DR Wesson (137_CR265) 2003; 35
SL Walsh (137_CR284) 1995; 119
LM Squeglia (137_CR283) 2019
L Gowing (137_CR268) 2016; 3
L Degenhardt (137_CR86) 2017; 5
SS Martins (137_CR71) 2012; 42
HD Nelson (137_CR175) 1996; 165
JM Bossert (137_CR130) 2005; 16
AR Levine (137_CR362) 2015; 54
137_CR386
137_CR387
ND Volkow (137_CR83) 2016; 352
GJ MacArthur (137_CR213) 2017; 39
J Macleod (137_CR66) 2013; 108
DA Fiellin (137_CR257) 2014; 174
M Doverty (137_CR161) 2001; 90
Y Fu (137_CR166) 2008; 28
WM Compton (137_CR206) 2016; 374
RC Dart (137_CR13) 2015; 372
XQ Feng (137_CR278) 2017; 10
P Moyo (137_CR198) 2017; 112
PJ Kenny (137_CR136) 2006; 26
S Luchenski (137_CR189) 2018; 391
D Dowell (137_CR41) 2016; 65
S Fazel (137_CR226) 2006; 101
137_CR195
DR
References_xml – ident: CR45
– volume: 5
  start-page: e578
  year: 2018
  end-page: e587
  ident: CR232
  article-title: Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study
  publication-title: Lancet HIV
  doi: 10.1016/S2352-3018(18)30168-1
– volume: 108
  start-page: 79
  year: 1992
  end-page: 84
  ident: CR127
  article-title: Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction
  publication-title: Psychopharmacology
  doi: 10.1007/BF02245289
– volume: 68
  start-page: 388
  year: 2019
  end-page: 395
  ident: CR204
  article-title: Drug overdose deaths involving cocaine and psychostimulants with abuse potential - united states, 2003-2017
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm6817a3
– volume: 14
  start-page: 543
  year: 1997
  end-page: 558
  ident: CR338
  article-title: Drug treatment careers. A conceptual framework and existing research findings
  publication-title: J.Subst. Abuse Treat.
  doi: 10.1016/S0740-5472(97)00016-0
– volume: 111
  start-page: 695
  year: 2016
  end-page: 705
  ident: CR288
  article-title: Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial
  publication-title: Addiction
  doi: 10.1111/add.13238
– volume: 37
  start-page: 95
  year: 2009
  end-page: 100
  ident: CR270
  article-title: Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2008.09.007
– volume: 219
  start-page: 427
  year: 2014
  end-page: 443
  ident: CR105
  article-title: β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia
  publication-title: Handb. Exp. Pharmacol.
  doi: 10.1007/978-3-642-41199-1_22
– ident: CR80
– volume: 109
  start-page: 90
  year: 2014
  end-page: 99
  ident: CR346
  article-title: Causes of death in a cohort treated for opioid dependence between 1985 and 2005
  publication-title: Addiction
  doi: 10.1111/add.12337
– volume: 87
  start-page: 1345
  year: 1992
  end-page: 1351
  ident: CR27
  article-title: The incidence of illicit drug use in the United States, 1962-1989
  publication-title: Br. J. Addict.
  doi: 10.1111/j.1360-0443.1992.tb02743.x
– volume: 27
  start-page: 633
  year: 2001
  end-page: 650
  ident: CR330
  article-title: Treatment process in prison therapeutic communities: motivation, participation, and outcome
  publication-title: Am. J. Drug Alcohol Abuse
  doi: 10.1081/ADA-100107660
– volume: 31
  start-page: 548
  year: 2007
  end-page: 563
  ident: CR32
  article-title: Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study
  publication-title: Eval. Rev.
  doi: 10.1177/0193841X07307315
– volume: 344
  year: 2012
  ident: CR9
  article-title: Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran
  publication-title: BMJ
  doi: 10.1136/bmj.e2502
– volume: 46
  start-page: 136
  year: 2017
  end-page: 145
  ident: CR78
  article-title: Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study
  publication-title: Int. J. Drug Policy
  doi: 10.1016/j.drugpo.2017.05.023
– volume: 6
  start-page: 44
  year: 2011
  end-page: 55
  ident: CR373
  article-title: The case for considering quality of life in addiction research and clinical practice
  publication-title: Addict. Sci. Clin. Pract.
– volume: 5
  start-page: CD004147
  year: 2011
  ident: CR317
  article-title: Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
  publication-title: Cochrane Database Syst. Rev.
– volume: 293
  start-page: 103
  year: 1986
  end-page: 104
  ident: CR267
  article-title: Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment
  publication-title: Br. Med. J.
  doi: 10.1136/bmj.293.6539.103
– volume: 290
  start-page: 78
  year: 2004
  end-page: 85
  ident: CR142
  article-title: The addicted brain
  publication-title: Sci. Am.
  doi: 10.1038/scientificamerican0304-78
– volume: 22
  start-page: 247
  year: 2001
  end-page: 256
  ident: CR328
  article-title: Methadone anonymous: a 12-step program for methadone maintained heroin addicts
  publication-title: Subst. Abus.
– volume: 47
  start-page: 293
  year: 2014
  end-page: 298
  ident: CR371
  article-title: The relationship between recovery and health-related quality of life
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2014.05.006
– volume: 8
  start-page: 1445
  year: 2005
  end-page: 1449
  ident: CR383
  article-title: Is there a common molecular pathway for addiction?
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn1578
– volume: 23
  start-page: 281
  year: 1995
  end-page: 302
  ident: CR60
  article-title: Childhood conduct problems and attention deficit behaviors and adolescent alcohol, tobacco and illicit drug use
  publication-title: J. Abnorm. Child Psychol.
  doi: 10.1007/BF01447558
– volume: 133
  start-page: 633
  year: 2013
  end-page: 640
  ident: CR322
  article-title: The twelve promises of alcoholics anonymous: psychometric measure validation and mediational testing as a 12-step specific mechanism of behavior change
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2013.08.006
– volume: 83
  start-page: 147
  year: 2006
  end-page: 156
  ident: CR29
  article-title: Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.11.007
– volume: 106
  start-page: 2186
  year: 2011
  end-page: 2192
  ident: CR178
  article-title: The increasing mortality burden of liver disease among opioid-dependent people: cohort study
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2011.03575.x
– ident: CR6
– volume: 7
  start-page: 289
  year: 1986
  end-page: 340
  ident: CR185
  article-title: Risks and prices: an economic analysis of drug enforcement
  publication-title: Crime Justice
  doi: 10.1086/449116
– volume: 114
  start-page: 1602
  year: 2019
  end-page: 1613
  ident: CR202
  article-title: Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic
  publication-title: Addiction
  doi: 10.1111/add.14664
– volume: 377
  start-page: 1506
  year: 2011
  end-page: 1513
  ident: CR307
  article-title: Injectable extended-release naltrexone for opioid dependence
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60358-9
– ident: CR315
– volume: 76
  start-page: 909
  year: 2015
  end-page: 915
  ident: CR347
  article-title: Patterns and correlates of sustained heroin abstinence: findings from the 11-year follow-up of the australian treatment outcome study
  publication-title: J. Stud. Alcohol. Drugs
  doi: 10.15288/jsad.2015.76.909
– volume: 16
  start-page: 1385
  year: 2016
  end-page: 1398
  ident: CR87
  article-title: Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the global burden of disease study 2013
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(16)30325-5
– volume: 24
  start-page: 152
  year: 2001
  end-page: 160
  ident: CR135
  article-title: Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00186-X
– volume: 112
  start-page: 605
  year: 2002
  end-page: 617
  ident: CR173
  article-title: Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory , and endocrine consequences of opiate withdrawal
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(02)00105-7
– volume: 99
  start-page: 697
  year: 2004
  end-page: 707
  ident: CR217
  article-title: Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the national treatment outcome research study (NTORS)
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2004.00752.x
– volume: 154
  start-page: 230
  year: 2001
  end-page: 242
  ident: CR285
  article-title: Effects of buprenorphine/naloxone in opioid-dependent humans
  publication-title: Psychopharmacology
  doi: 10.1007/s002130000637
– volume: 79
  start-page: 231
  year: 2005
  end-page: 240
  ident: CR28
  article-title: Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam cohort study among drug users
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.01.013
– volume: 352
  start-page: i19
  year: 2016
  ident: CR83
  article-title: Opioids in pregnancy
  publication-title: BMJ
  doi: 10.1136/bmj.i19
– volume: 33
  start-page: 229
  year: 2007
  end-page: 241
  ident: CR325
  article-title: Addiction recovery: its definition and conceptual boundaries
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2007.04.015
– volume: 112
  start-page: 1408
  year: 2017
  end-page: 1418
  ident: CR224
  article-title: Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
  publication-title: Addiction
  doi: 10.1111/add.13779
– volume: 105
  start-page: 1545
  year: 2010
  end-page: 1554
  ident: CR23
  article-title: Meta-analysis of drug-related deaths soon after release from prison
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2010.02990.x
– ident: CR314
– ident: CR93
– volume: 100
  start-page: 1496
  year: 2005
  end-page: 1509
  ident: CR277
  article-title: Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.01232.x
– volume: 167
  start-page: 293
  year: 2017
  end-page: 301
  ident: CR14
  article-title: Prescription opioid use, misuse, and use disorders in u.s. adults: 2015 national survey on drug use and health
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M17-0865
– volume: 110
  start-page: 646
  year: 2015
  end-page: 655
  ident: CR365
  article-title: A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
  publication-title: Addiction
  doi: 10.1111/add.12834
– start-page: e218
  year: 2018
  end-page: e225
  ident: CR241
  article-title: Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study
  publication-title: Lancet Public Health
– volume: 142
  start-page: 33
  year: 2014
  end-page: 40
  ident: CR337
  article-title: A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.05.011
– volume: 6
  start-page: 95
  year: 2017
  ident: CR358
  article-title: Quality of life of adolescents and young people arrive at an addiction treatment centers upon their admission, and 1, 4 and 8 months after methadone maintenance therapy
  publication-title: J. Educ. Health Promot
  doi: 10.4103/jehp.jehp_297_13
– volume: 21
  start-page: 364
  year: 2010
  end-page: 380
  ident: CR376
  article-title: Quality of life among opiate-dependent individuals: a review of the literature
  publication-title: Int. J. Drug. Policy
  doi: 10.1016/j.drugpo.2010.01.010
– volume: 158
  start-page: 833
  year: 2017
  end-page: 839
  ident: CR201
  article-title: Impact of the opioid safety initiative on opioid-related prescribing in veterans
  publication-title: Pain
  doi: 10.1097/j.pain.0000000000000837
– volume: 113
  start-page: 173
  year: 2018
  end-page: 182
  ident: CR231
  article-title: Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic
  publication-title: Addiction
  doi: 10.1111/add.13948
– volume: 15
  start-page: 211
  year: 2008
  end-page: 218
  ident: CR238
  article-title: Family carers and the prevention of heroin overdose deaths: unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone
  publication-title: Drugs Educ. Prevent. Policy
  doi: 10.1080/09687630701731205
– volume: 2
  year: 2019
  ident: CR193
  article-title: Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder
  publication-title: JAMA Netw. Open
  doi: 10.1001/jamanetworkopen.2019.6373
– volume: 9
  start-page: CD012880
  year: 2019
  ident: CR329
  article-title: Alcoholics Anonymous and other 12-step programs for alcohol use disorder
  publication-title: Cochrane Database Syst. Rev.
– volume: 65
  start-page: 1
  year: 2016
  end-page: 49
  ident: CR36
  article-title: CDC guideline for prescribing opioids for chronic pain – United States, 2016
  publication-title: MMWR Recomm. Rep.
  doi: 10.15585/mmwr.rr6501e1
– volume: 99
  start-page: 183
  year: 2009
  end-page: 192
  ident: CR116
  article-title: Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2008.07.012
– volume: 5
  start-page: e1192
  year: 2017
  end-page: e1207
  ident: CR86
  article-title: Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
  publication-title: Lancet Glob. Health
  doi: 10.1016/S2214-109X(17)30375-3
– volume: 23
  start-page: 238
  year: 2017
  end-page: 248
  ident: CR374
  article-title: Development of OSTQOL: a measure of quality of life for patients in opioid substitution treatment
  publication-title: Eur. Addict. Res.
  doi: 10.1159/000484239
– volume: 100
  start-page: 1101
  year: 2005
  end-page: 1109
  ident: CR293
  article-title: Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.001128.x
– volume: 59
  start-page: 1411
  year: 2014
  end-page: 1419
  ident: CR81
  article-title: Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciu643
– volume: 62
  start-page: 1157
  year: 2005
  end-page: 1164
  ident: CR354
  article-title: Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.62.10.1157
– volume: 29
  start-page: 14764
  year: 2009
  end-page: 14769
  ident: CR163
  article-title: Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4291-09.2009
– volume: 166
  start-page: 26
  year: 2016
  end-page: 31
  ident: CR162
  article-title: Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2016.06.024
– volume: 146
  start-page: 17
  year: 2015
  end-page: 23
  ident: CR177
  article-title: National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.09.782
– volume: 131
  start-page: 823
  year: 2012
  end-page: 842
  ident: CR144
  article-title: The genetics of the opioid system and specific drug addictions
  publication-title: Hum. Genet.
  doi: 10.1007/s00439-012-1172-4
– volume: 16
  start-page: 633
  year: 2015
  end-page: 641
  ident: CR50
  article-title: Racial/ethnic differences in factors that place adolescents at risk for prescription opioid misuse
  publication-title: Prev. Sci.
  doi: 10.1007/s11121-014-0514-y
– ident: CR386
– volume: 66
  start-page: 825
  year: 2009
  end-page: 833
  ident: CR281
  article-title: Methadone-associated QT interval prolongation and torsades de pointes
  publication-title: Am. J. Health Syst. Pharm.
  doi: 10.2146/ajhp070392
– volume: 63
  start-page: 102
  year: 2006
  end-page: 109
  ident: CR321
  article-title: A randomized controlled trial of interim methadone maintenance
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.63.1.102
– volume: 66
  start-page: 382
  year: 2017
  end-page: 386
  ident: CR79
  article-title: Characteristics of fentanyl overdose — Massachusetts, 2014–2016
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm6614a2
– volume: 77
  start-page: 772
  year: 2016
  end-page: 780
  ident: CR34
  article-title: Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States
  publication-title: J. Clin. Psychiatry
  doi: 10.4088/JCP.15m10386
– volume: 28
  start-page: 251
  year: 1996
  end-page: 257
  ident: CR109
  article-title: Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal
  publication-title: J. Psychoact. Drugs
  doi: 10.1080/02791072.1996.10472486
– volume: 21
  start-page: 74
  year: 2013
  end-page: 83
  ident: CR306
  article-title: Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users
  publication-title: Exp. Clin. Psychopharmacol.
  doi: 10.1037/a0030743
– volume: 31
  start-page: 199
  year: 2012
  end-page: 206
  ident: CR326
  article-title: Medication-assisted recovery from opioid addiction: historical and contemporary perspectives
  publication-title: J. Addict. Dis.
  doi: 10.1080/10550887.2012.694597
– volume: 52
  start-page: 157
  year: 1990
  end-page: 169
  ident: CR58
  article-title: Divorce, remarriage, and adolescent drug involvement: a prospective longitudinal study
  publication-title: J. Marriage Family
  doi: 10.2307/352847
– volume: 355
  start-page: 365
  year: 2006
  end-page: 374
  ident: CR319
  article-title: Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa055255
– volume: 87
  start-page: 1644
  year: 2016
  end-page: 1656
  ident: CR190
  article-title: Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00161-6
– ident: CR387
– volume: 247
  start-page: 47
  year: 1988
  end-page: 53
  ident: CR274
  article-title: Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 243
  start-page: 91
  year: 1982
  end-page: 105
  ident: CR96
  article-title: Drug reinforcement studied by the use of place conditioning in rat
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(82)91123-4
– volume: 108
  start-page: 1675
  year: 2018
  end-page: 1681
  ident: CR5
  article-title: Estimated prevalence of opioid use disorder in massachusetts, 2011-2015: a capture-recapture analysis
  publication-title: Am. J. Public Health
  doi: 10.2105/AJPH.2018.304673
– volume: 78
  start-page: 474
  year: 2015
  end-page: 484
  ident: CR146
  article-title: Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2015.01.003
– volume: 16
  start-page: CD001333
  year: 2011
  ident: CR305
  article-title: Oral naltrexone maintenance treatment for opioid dependence
  publication-title: Cochrane Database Syst. Rev.
– volume: 76
  start-page: 88
  year: 2017
  end-page: 93
  ident: CR370
  article-title: Quality of life as an outcome of opioid use disorder treatment: a systematic review
  publication-title: J. Substance Abuse Treat.
  doi: 10.1016/j.jsat.2017.01.019
– volume: 28
  start-page: 142
  year: 2009
  end-page: 153
  ident: CR54
  article-title: Is socioeconomic status in early life associated with drug use? A systematic review of the evidence
  publication-title: Drug Alcohol Rev.
  doi: 10.1111/j.1465-3362.2008.00042.x
– volume: 74
  start-page: 445
  year: 2017
  end-page: 455
  ident: CR16
  article-title: Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001-2002 to 2012-2013 national epidemiologic survey on alcohol and related conditions
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2017.0113
– volume: 341
  start-page: c3172
  year: 2010
  ident: CR30
  article-title: Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment
  publication-title: BMJ
  doi: 10.1136/bmj.c3172
– volume: 108
  start-page: 1296
  year: 2013
  end-page: 1304
  ident: CR229
  article-title: Low incidence of hepatitis C virus amongst prisoners in Scotland
  publication-title: Addiction
  doi: 10.1111/add.12107
– ident: CR209
– volume: 113
  start-page: 545
  year: 2018
  end-page: 563
  ident: CR215
  article-title: Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis
  publication-title: Addiction
  doi: 10.1111/add.14012
– volume: 31
  start-page: 2692
  year: 2006
  end-page: 2707
  ident: CR95
  article-title: Unlimited access to heroin self-administration: independent motivational markers of opiate dependence
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301008
– volume: 753
  start-page: 73
  year: 2015
  end-page: 87
  ident: CR112
  article-title: The dark side of emotion: the addiction perspective
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2014.11.044
– volume: 10
  start-page: 295
  year: 2007
  end-page: 317
  ident: CR61
  article-title: A systematic review of the relationship between high school dropout and substance use
  publication-title: Clin. Child Family Psychol. Rev.
  doi: 10.1007/s10567-007-0023-7
– volume: 17
  year: 2017
  ident: CR68
  article-title: Relationship between interpersonal trauma exposure and addictive behaviors: a systematic review
  publication-title: BMC Psychiatry
  doi: 10.1186/s12888-017-1323-1
– volume: 38
  start-page: 3
  year: 2017
  end-page: 8
  ident: CR205
  article-title: Turning the tide or riptide? The changing opioid epidemic
  publication-title: Subst. Abus.
  doi: 10.1080/08897077.2016.1261070
– volume: 39
  start-page: 121
  year: 2017
  end-page: 129
  ident: CR248
  article-title: Drug decriminalization and the price of illicit drugs
  publication-title: Int. J. Drug Policy
  doi: 10.1016/j.drugpo.2016.10.014
– volume: 79
  start-page: 434
  year: 2002
  end-page: 435
  ident: CR180
  article-title: Population impact of mass incarceration under New York’s rockefeller drug laws: an analysis of years of life lost
  publication-title: J. Urban Health
  doi: 10.1093/jurban/79.3.434
– ident: CR291
– volume: 18
  start-page: 381
  year: 2009
  end-page: 395
  ident: CR25
  article-title: Estimating the prevalence of ex-injecting drug use in the population
  publication-title: Stat. Methods Med. Res.
  doi: 10.1177/0962280208094704
– volume: 38
  start-page: 265
  year: 2017
  end-page: 268
  ident: CR44
  article-title: Self-regulating profession? Administrative discipline of “pill mill” physicians in Florida
  publication-title: Subst. Abus.
  doi: 10.1080/08897077.2017.1316812
– volume: 108
  start-page: 84
  year: 2010
  end-page: 97
  ident: CR73
  article-title: Evaluating the drug use “gateway” theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the who world mental health surveys
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2009.12.001
– volume: 96
  start-page: 167
  year: 2008
  end-page: 177
  ident: CR52
  article-title: The developmental antecedents of illicit drug use: evidence from a 25 year longitudinal study
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2008.03.003
– volume: 28
  start-page: 32
  year: 2004
  end-page: 36
  ident: CR335
  article-title: Risk of death in prisoners after release from jail
  publication-title: Aust. N. Z. J. Public. Health
  doi: 10.1111/j.1467-842X.2004.tb00629.x
– year: 2017
  ident: CR239
  article-title: Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-conception and maturation
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2017.05.001
– volume: 58
  start-page: 503
  year: 2001
  end-page: 508
  ident: CR21
  article-title: A 33-year follow-up of narcotics addicts
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.58.5.503
– volume: 178
  start-page: 764
  year: 2018
  end-page: 773
  ident: CR292
  article-title: Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2018.1052
– ident: CR221
– volume: 108
  start-page: 182
  year: 2018
  end-page: 186
  ident: CR72
  article-title: Opioid crisis: no easy fix to its social and economic determinants
  publication-title: Am. J. Public Health
  doi: 10.2105/AJPH.2017.304187
– volume: 13
  start-page: 18
  year: 2018
  ident: CR334
  article-title: Emergency department screening and interventions for substance use disorders
  publication-title: Addict. Sci. Clin. Pract.
  doi: 10.1186/s13722-018-0117-1
– volume: 25
  start-page: 297
  year: 2006
  end-page: 305
  ident: CR187
  article-title: Documenting the heroin shortage in New South Wales
  publication-title: Drug. Alcohol. Rev.
  doi: 10.1080/09595230600741024
– volume: 36
  start-page: 195
  year: 2013
  end-page: 206
  ident: CR92
  article-title: Opioid receptors: distinct roles in mood disorders
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2012.11.002
– volume: 16
  start-page: 1013
  year: 2005
  end-page: 1016
  ident: CR130
  article-title: The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking
  publication-title: Neuroreport
  doi: 10.1097/00001756-200506210-00026
– volume: 22
  start-page: 241
  year: 1999
  end-page: 252
  ident: CR153
  article-title: Gender differences in substance use disorders
  publication-title: Psychiatr. Clin. North Am.
  doi: 10.1016/S0193-953X(05)70074-5
– volume: 90
  start-page: 91
  year: 2001
  end-page: 96
  ident: CR161
  article-title: Hyperalgesic responses in methadone maintenance patients
  publication-title: Pain
  doi: 10.1016/S0304-3959(00)00391-2
– volume: 94
  start-page: 199
  year: 1999
  end-page: 204
  ident: CR237
  article-title: Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.1999.9421993.x
– volume: 31
  start-page: 64
  year: 2007
  end-page: 68
  ident: CR323
  article-title: Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes
  publication-title: Alcohol Clin. Exp. Res.
  doi: 10.1111/j.1530-0277.2006.00273.x
– volume: 23
  start-page: 76
  year: 2015
  end-page: 89
  ident: CR342
  article-title: Long-term course of opioid addiction
  publication-title: Harv. Rev. Psychiatry
  doi: 10.1097/HRP.0000000000000052
– volume: 25
  start-page: CD004330
  year: 2005
  ident: CR360
  article-title: Psychosocial treatment for opiate abuse and dependence
  publication-title: Cochrane Database Syst. Rev.
– ident: CR47
– volume: 6
  start-page: 639
  year: 2019
  end-page: 640
  ident: CR352
  article-title: Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(19)30209-3
– volume: 315
  start-page: 1624
  year: 2016
  end-page: 1645
  ident: CR37
  article-title: CDC guideline for prescribing opioids for chronic pain – United States, 2016
  publication-title: JAMA
  doi: 10.1001/jama.2016.1464
– volume: 341
  start-page: c5475
  year: 2010
  ident: CR233
  article-title: Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK general practice research database
  publication-title: BMJ
  doi: 10.1136/bmj.c5475
– volume: 369
  start-page: 1047
  year: 2007
  end-page: 1053
  ident: CR18
  article-title: Development of a rational scale to assess the harm of drugs of potential misuse
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60464-4
– volume: 132
  start-page: 128
  year: 2012
  end-page: 134
  ident: CR182
  article-title: Universal alcohol misuse prevention programmes for children and adolescents: cochrane systematic reviews
  publication-title: Perspect. Public Health
  doi: 10.1177/1757913912443487
– volume: 2
  start-page: 137
  year: 2005
  end-page: 145
  ident: CR155
  article-title: Sex differences in pain perception
  publication-title: Gend. Med.
  doi: 10.1016/S1550-8579(05)80042-7
– volume: 39
  start-page: 1968
  year: 2014
  end-page: 1977
  ident: CR103
  article-title: Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.45
– volume: 91
  start-page: 295
  year: 2009
  end-page: 302
  ident: CR119
  article-title: The α1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration
  publication-title: Pharmacol. Biochem. Behav.
  doi: 10.1016/j.pbb.2008.07.012
– volume: 110
  start-page: 1975
  year: 2015
  end-page: 1984
  ident: CR220
  article-title: A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence
  publication-title: Addiction
  doi: 10.1111/add.13073
– volume: 103
  start-page: 251
  year: 2008
  end-page: 255
  ident: CR261
  article-title: Acute risk of drug-related death among newly released prisoners in England and Wales
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.02081.x
– volume: 109
  start-page: 617
  year: 2014
  end-page: 626
  ident: CR294
  article-title: Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone
  publication-title: Addiction
  doi: 10.1111/add.12440
– volume: 119
  start-page: 268
  year: 1995
  end-page: 276
  ident: CR284
  article-title: Effects of buprenorphine and methadone in methadone-maintained subjects
  publication-title: Psychopharmacology
  doi: 10.1007/BF02246290
– year: 2019
  ident: CR283
  article-title: Pharmacological treatment of youth substance use disorders
  publication-title: J. Child Adolesc. Psychopharmacol.
  doi: 10.1089/cap.2019.0009
– volume: 108
  start-page: 743
  year: 2013
  end-page: 750
  ident: CR66
  article-title: Early life influences on the risk of injecting drug use: case control study based on the edinburgh addiction cohort
  publication-title: Addiction
  doi: 10.1111/add.12056
– volume: 111
  start-page: 1177
  year: 2016
  end-page: 1187
  ident: CR240
  article-title: Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria
  publication-title: Addiction
  doi: 10.1111/add.13326
– volume: 408
  start-page: 720
  year: 2000
  end-page: 723
  ident: CR106
  article-title: Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence
  publication-title: Nature
  doi: 10.1038/35047086
– volume: 10
  start-page: 1225
  year: 2017
  end-page: 1239
  ident: CR278
  article-title: Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management
  publication-title: J. Pain. Res.
  doi: 10.2147/JPR.S138698
– volume: 11
  start-page: 315
  year: 2017
  end-page: 319
  ident: CR345
  article-title: High mortality among patients with opioid use disorder in a large healthcare system
  publication-title: J. Addict. Med.
  doi: 10.1097/ADM.0000000000000312
– volume: 23
  start-page: 559
  year: 2013
  end-page: 563
  ident: CR384
  article-title: Negative reinforcement in drug addiction: the darkness within
  publication-title: Curr. Opin. Neurobiol.
  doi: 10.1016/j.conb.2013.03.011
– volume: 42
  start-page: 1261
  year: 2012
  end-page: 1272
  ident: CR71
  article-title: Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the national epidemiologic study on alcohol and related conditions
  publication-title: Psychol. Med.
  doi: 10.1017/S0033291711002145
– volume: 174
  start-page: 1947
  year: 2014
  end-page: 1954
  ident: CR257
  article-title: Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2014.5302
– volume: 6
  start-page: 205
  year: 2016
  end-page: 214
  ident: CR158
  article-title: PET imaging reveals sex differences in κ opioid receptor availability in humans, in vivo
  publication-title: Am. J. Nucl. Med. Mol. Imaging
– volume: 33
  start-page: 13
  year: 2014
  end-page: 18
  ident: CR369
  article-title: Recovery-oriented policy and care systems in the UK and USA
  publication-title: Drug Alcohol Rev.
  doi: 10.1111/dar.12092
– volume: 89
  start-page: 1379
  year: 2009
  end-page: 1412
  ident: CR97
  article-title: Reward processing by the opioid system in the brain
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00005.2009
– volume: 318
  start-page: 1065
  year: 2017
  end-page: 1067
  ident: CR348
  article-title: Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015
  publication-title: JAMA.
  doi: 10.1001/jama.2017.9308
– volume: 171
  start-page: 1165
  year: 2017
  end-page: 1175
  ident: CR107
  article-title: Bias factor and therapeutic window correlate to predict safer opioid analgesics
  publication-title: Cell
  doi: 10.1016/j.cell.2017.10.035
– volume: 33
  start-page: 1122
  year: 1994
  end-page: 1131
  ident: CR56
  article-title: Parental separation, adolescent psychopathology , and problem behaviors
  publication-title: J. Am. Acad. Child Adolesc. Psychiatry
  doi: 10.1097/00004583-199410000-00008
– volume: 19
  start-page: 375
  year: 2000
  end-page: 382
  ident: CR331
  article-title: Therapeutic communities. Enhancing retention in treatment using “Senior professor” staff
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/S0740-5472(00)00124-0
– volume: 107
  start-page: 2983
  year: 2018
  end-page: 2991
  ident: CR279
  article-title: Methadone metabolism and drug-drug interactions: in vitro and in vivo literature review
  publication-title: J. Pharm. Sci.
  doi: 10.1016/j.xphs.2018.08.025
– volume: 151
  start-page: 567
  year: 2010
  end-page: 568
  ident: CR63
  article-title: Who gets high‐dose opioid therapy for chronic non‐cancer pain?
  publication-title: Pain
  doi: 10.1016/j.pain.2010.08.036
– volume: 70
  start-page: 1347
  year: 2013
  end-page: 1354
  ident: CR272
  article-title: A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.2216
– volume: 80
  start-page: 267
  year: 2005
  end-page: 271
  ident: CR296
  article-title: The effects of racemic D, L-methadone and L-methadone in substituted patients-a randomized controlled study
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.04.007
– ident: CR174
– ident: CR46
– volume: 1
  start-page: 232
  year: 1996
  end-page: 254
  ident: CR132
  article-title: Opiates, opioids and addiction
  publication-title: Mol. Psychiatry
– volume: 374
  start-page: 1253
  year: 2016
  end-page: 1263
  ident: CR108
  article-title: Opioid abuse in chronic pain-misconceptions and mitigation strategies
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1507771
– volume: 391
  start-page: 266
  year: 2018
  end-page: 280
  ident: CR189
  article-title: What works in inclusion health: overview of effective interventions for marginalised and excluded populations
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)31959-1
– volume: 79
  start-page: 1395
  issue: 13
  year: 2019
  end-page: 1418
  ident: CR332
  article-title: Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine
  publication-title: Drugs
  doi: 10.1007/s40265-019-01154-5
– volume: 161
  start-page: 202
  year: 2002
  end-page: 212
  ident: CR275
  article-title: High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-002-1027-0
– volume: 63
  start-page: 1094
  year: 2016
  end-page: 1104
  ident: CR218
  article-title: Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciw416
– ident: CR246
– volume: 73
  start-page: 568
  year: 1995
  end-page: 585
  ident: CR172
  article-title: Spino (trigemino) parabrachiohypothalamic pathway: electrophysiological evidence for an involvement in pain processes
  publication-title: J. Neurophysiol.
  doi: 10.1152/jn.1995.73.2.568
– year: 2019
  ident: CR192
  article-title: Predictors of overdose death among high-risk emergency department patients with substance-related encounters: a data linkage cohort study
  publication-title: Ann. Emerg. Med.
  doi: 10.1016/j.annemergmed.2019.07.014
– volume: 24
  start-page: 97
  year: 2001
  end-page: 129
  ident: CR168
  article-title: Drug addiction, dysregulation of reward, and allostasis
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00195-0
– volume: 165
  start-page: 31
  year: 1996
  end-page: 36
  ident: CR175
  article-title: Substance-impaired physicians probationary and voluntary treatment programs compared
  publication-title: West. J. Med.
– volume: 2015
  start-page: 368979
  year: 2015
  ident: CR145
  article-title: Pharmacogenomics and opioid analgesics: clinical implications
  publication-title: Int. J. Genomics
  doi: 10.1155/2015/368979
– volume: 75
  start-page: 999
  year: 2014
  end-page: 1010
  ident: CR367
  article-title: Elements that define recovery: the experiential perspective
  publication-title: J. Stud. Alcohol. Drugs
  doi: 10.15288/jsad.2014.75.999
– ident: CR316
– volume: 393
  start-page: 1760
  year: 2019
  end-page: 1772
  ident: CR1
  article-title: Management of opioid use disorder in the USA: present status and future directions
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)33078-2
– volume: 108
  start-page: 65
  year: 2010
  end-page: 69
  ident: CR333
  article-title: Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2009.11.008
– volume: 394
  start-page: 1560
  year: 2019
  end-page: 1579
  ident: CR38
  article-title: Global patterns of opioid use and dependence: harms to populations, interventions, and future action
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)32229-9
– ident: CR152
– volume: 47
  start-page: 149
  year: 2015
  end-page: 157
  ident: CR356
  article-title: Changes in quality of life following buprenorphine treatment: relationship with treatment retention and illicit opioid use
  publication-title: J. Psychoact. Drugs
  doi: 10.1080/02791072.2015.1014948
– volume: 390
  start-page: 1211
  year: 2017
  end-page: 1259
  ident: CR8
  article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32154-2
– volume: 36
  start-page: 559
  year: 2015
  end-page: 574
  ident: CR40
  article-title: The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction
  publication-title: Annu. Rev. Public Health
  doi: 10.1146/annurev-publhealth-031914-122957
– volume: 33
  start-page: 13
  year: 2000
  end-page: 33
  ident: CR131
  article-title: Stress-induced relapse to heroin and cocaine seeking in rats: a review
  publication-title: Brain Res. Rev.
  doi: 10.1016/S0165-0173(00)00024-2
– volume: 191
  start-page: 55
  year: 2007
  end-page: 62
  ident: CR299
  article-title: Heroin-assisted treatment for opioid dependence: randomised controlled trial
  publication-title: Br. J. Psychiatry
  doi: 10.1192/bjp.bp.106.026112
– volume: 2
  start-page: 485
  year: 1979
  end-page: 488
  ident: CR259
  article-title: Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong
  publication-title: Lancet
  doi: 10.1016/S0140-6736(79)91550-2
– volume: 316
  start-page: 426
  year: 1998
  end-page: 428
  ident: CR260
  article-title: Mortality from overdose among injecting drug users recently released from prison: database linkage study
  publication-title: BMJ
  doi: 10.1136/bmj.316.7129.426
– year: 2011
  ident: CR318
  article-title: Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.121
– volume: 233
  start-page: 1991
  year: 2016
  end-page: 2004
  ident: CR129
  article-title: Role of projections from ventral subiculum to nucleus accumbens shell in context-induced reinstatement of heroin seeking in rats
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-015-4060-5
– volume: 76
  start-page: 66
  year: 2014
  end-page: 74
  ident: CR149
  article-title: Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2013.08.034
– volume: 113
  start-page: 729
  year: 2018
  end-page: 739
  ident: CR344
  article-title: Patterns of substance use and mortality risk in a cohort of ‘hard-to-reach’ polysubstance users
  publication-title: Addiction
  doi: 10.1111/add.14053
– volume: 35
  start-page: 501
  year: 1978
  end-page: 516
  ident: CR282
  article-title: Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.1978.01770280111012
– volume: 15
  start-page: 580
  year: 2015
  end-page: 594
  ident: CR147
  article-title: Association between human pain-related genotypes and variability in opioid analgesia: an updated review
  publication-title: Pain Pract.
  doi: 10.1111/papr.12232
– volume: 375
  start-page: 2504
  year: 2016
  end-page: 2505
  ident: CR320
  article-title: Interim buprenorphine vs. waiting list for opioid dependence
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc1610047
– volume: 63
  start-page: 563
  year: 2014
  end-page: 568
  ident: CR39
  article-title: Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines – United States, 2012
  publication-title: MMWR Morb. Mortal. Wkly Rep.
– volume: 284
  start-page: 1689
  year: 2000
  end-page: 1695
  ident: CR222
  article-title: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation
  publication-title: JAMA
  doi: 10.1001/jama.284.13.1689
– volume: 23
  start-page: 31
  year: 2015
  end-page: 40
  ident: CR378
  article-title: Emerging consensus on measuring addiction recovery: findings from a multi-stakeholder consultation exercise
  publication-title: Drugs Educ. Prev. Policy
  doi: 10.3109/09687637.2015.1100587
– year: 2016
  ident: CR183
  article-title: Prevention, early intervention, harm reduction, and treatment of substance use in young people
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)00002-X
– volume: 66
  start-page: 1197
  year: 2017
  end-page: 1202
  ident: CR75
  article-title: Deaths involving fentanyl, fentanyl analogs, and U-47700 — 10 states, July–December 2016
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm6643e1
– volume: 8
  start-page: CD002209
  year: 2009
  ident: CR211
  article-title: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
  publication-title: Cochrane Database Syst. Rev
– volume: 178
  start-page: 861
  year: 2018
  end-page: 863
  ident: CR42
  article-title: Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2018.1999
– volume: 101
  start-page: 181
  year: 2006
  end-page: 191
  ident: CR226
  article-title: Substance abuse and dependence in prisoners: a systematic review
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01316.x
– volume: 169
  start-page: 137
  year: 2018
  end-page: 145
  ident: CR310
  article-title: Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M17-3107
– volume: 288
  start-page: 1769
  year: 2000
  end-page: 1772
  ident: CR171
  article-title: Psychological and neural mechanisms of the affective dimension of pain
  publication-title: Science
  doi: 10.1126/science.288.5472.1769
– ident: CR51
– volume: 112
  start-page: 1784
  year: 2017
  end-page: 1796
  ident: CR198
  article-title: Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among medicare beneficiaries in 10 US States
  publication-title: Addiction
  doi: 10.1111/add.13860
– volume: 57
  start-page: S39
  issue: Suppl. 2
  year: 2013
  end-page: S45
  ident: CR385
  article-title: Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cit296
– volume: 69
  start-page: 57
  year: 2016
  end-page: 63
  ident: CR252
  article-title: HIV patients’ preference for integrated models of addiction and HIV treatment in Vietnam
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2016.07.003
– volume: 10
  start-page: 561
  year: 2009
  end-page: 572
  ident: CR128
  article-title: The glutamate homeostasis hypothesis of addiction
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn2515
– volume: 11
  start-page: 1092
  year: 2010
  end-page: 1098
  ident: CR169
  article-title: Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain
  publication-title: Pain Med.
  doi: 10.1111/j.1526-4637.2010.00881.x
– volume: 4
  start-page: 511
  year: 2003
  end-page: 519
  ident: CR160
  article-title: Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study
  publication-title: J. Pain
  doi: 10.1016/j.jpain.2003.08.003
– volume: 36
  start-page: 18
  year: 2016
  end-page: 26
  ident: CR290
  article-title: Sustained-release buprenorphine (RBP-6000) blocks the effects of opioid challenge with hydromorphone in subjects with opioid use disorder
  publication-title: J. Clin. Psychopharmacology
  doi: 10.1097/JCP.0000000000000434
– volume: 25
  start-page: 307
  year: 2006
  end-page: 313
  ident: CR188
  article-title: Changes in the initiation of heroin use after a reduction in heroin supply
  publication-title: Drug. Alcohol. Rev.
  doi: 10.1080/09595230600741040
– volume: 16
  start-page: 1323
  year: 2016
  end-page: 1327
  ident: CR74
  article-title: Increases in drug and opioid overdose deaths — United States, 2000–2014
  publication-title: Am. J. Transplant.
  doi: 10.1111/ajt.13776
– volume: 98
  start-page: 427
  year: 2003
  end-page: 439
  ident: CR269
  article-title: Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.2003.00372.x
– volume: 64
  start-page: 453
  year: 2015
  end-page: 458
  ident: CR82
  article-title: Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years – Kentucky , Tennessee, Virginia, and West Virginia, 2006–2012
  publication-title: MMWR Morb. Mortal. Wkly Rep.
– volume: 189
  start-page: 1
  year: 2015
  end-page: 8
  ident: CR12
  article-title: Prescription opioid analgesic use among adults: United States, 1999-2012
  publication-title: NCHS Data Brief
– volume: 28
  start-page: 286
  year: 1973
  end-page: 295
  ident: CR100
  article-title: Methadone – a reevaluation
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.1973.01750320112017
– volume: 361
  year: 2018
  ident: CR186
  article-title: Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016
  publication-title: Science
  doi: 10.1126/science.aau1184
– volume: 47
  start-page: 165
  year: 2017
  end-page: 171
  ident: CR69
  article-title: Developmental trajectories to heroin dependence: theoretical and clinical issues
  publication-title: J. Appl. Soc. Psychol.
  doi: 10.1111/jasp.12434
– volume: 566
  start-page: 348
  year: 1991
  end-page: 350
  ident: CR113
  article-title: Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(91)91724-F
– volume: 15
  start-page: 829
  year: 1941
  end-page: 839
  ident: CR266
  article-title: The morphine abstinence syndrome, its nature and treatment
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-15-5-829
– volume: 25
  start-page: 177
  year: 2003
  end-page: 186
  ident: CR380
  article-title: Recovery from opioid addiction in DATOS
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/S0740-5472(03)00125-9
– volume: 16
  start-page: 1745
  year: 2015
  end-page: 1758
  ident: CR59
  article-title: Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment (POINT) cohort
  publication-title: Pain. Med.
  doi: 10.1111/pme.12773
– volume: 14
  start-page: 130
  year: 2009
  end-page: 143
  ident: CR118
  article-title: Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2008.00142.x
– volume: 28
  start-page: 3861
  year: 2008
  end-page: 3876
  ident: CR166
  article-title: Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0227-08.2008
– volume: 179
  start-page: 291
  year: 2017
  end-page: 298
  ident: CR351
  article-title: Trends in heroin and pharmaceutical opioid overdose deaths in Australia
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2017.07.018
– volume: 5
  start-page: 253
  year: 2014
  ident: CR102
  article-title: Does the κ opioid receptor system contribute to pain aversion?
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2014.00253
– volume: 18
  start-page: 22
  year: 1995
  end-page: 29
  ident: CR91
  article-title: Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
  publication-title: Trends Neurosci.
  doi: 10.1016/0166-2236(95)93946-U
– volume: 149
  start-page: 115
  year: 2000
  end-page: 120
  ident: CR134
  article-title: Opiate withdrawal-induced place aversion lasts for up to 16 weeks
  publication-title: Psychopharmacology
  doi: 10.1007/s002139900358
– volume: 156
  start-page: 842
  year: 1999
  end-page: 848
  ident: CR156
  article-title: Gender and age influences on human brain mu-opioid receptor binding measured by PET
  publication-title: Am. J. Psychiatry
  doi: 10.1176/ajp.156.6.842
– volume: 200
  start-page: 34
  year: 2019
  end-page: 39
  ident: CR311
  article-title: Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort
  publication-title: Drug. Alcohol. Depend.
  doi: 10.1016/j.drugalcdep.2019.02.031
– ident: CR207
– volume: 134
  start-page: 251
  year: 2014
  end-page: 258
  ident: CR372
  article-title: Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review
  publication-title: Drug. Alcohol. Depend.
  doi: 10.1016/j.drugalcdep.2013.10.011
– volume: 357
  start-page: j1550
  year: 2017
  ident: CR22
  article-title: Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
  publication-title: BMJ
  doi: 10.1136/bmj.j1550
– volume: 41
  start-page: 373
  year: 2016
  end-page: 374
  ident: CR122
  article-title: Dynorphin, dysphoria, and dependence: the stress of addiction
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2015.258
– volume: 83
  start-page: S4
  year: 2006
  end-page: S7
  ident: CR48
  article-title: Abuse of prescription drugs and the risk of addiction
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.10.020
– volume: 372
  start-page: 241
  year: 2015
  end-page: 248
  ident: CR13
  article-title: Trends in opioid analgesic abuse and mortality in the United States
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMsa1406143
– volume: 374
  start-page: 1232
  year: 2016
  end-page: 1242
  ident: CR336
  article-title: Extended-release naltrexone to prevent opioid relapse in criminal justice offenders
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1505409
– volume: 89
  start-page: 631
  year: 1999
  end-page: 636
  ident: CR99
  article-title: Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(98)00652-6
– volume: 73
  start-page: 447
  year: 2016
  end-page: 455
  ident: CR304
  article-title: Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2016.0109
– volume: 4
  year: 2014
  ident: CR228
  article-title: Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
  publication-title: BMJ Open.
  doi: 10.1136/bmjopen-2013-004666
– volume: 2
  year: 2019
  ident: CR43
  article-title: Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses
  publication-title: JAMA Netw. Open.
  doi: 10.1001/jamanetworkopen.2018.6007
– volume: 376
  start-page: 285
  year: 2010
  end-page: 301
  ident: CR33
  article-title: Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60742-8
– volume: 26
  start-page: 199
  year: 2015
  end-page: 209
  ident: CR249
  article-title: A social cost perspective in the wake of the Portuguese strategy for the fight against drugs
  publication-title: Int. J. Drug Policy
  doi: 10.1016/j.drugpo.2014.08.017
– volume: 12
  start-page: CD003020
  year: 2014
  ident: CR181
  article-title: Universal school-based prevention for illicit drug use
  publication-title: Cochrane Database Syst. Rev.
– volume: 67
  start-page: 247
  year: 2006
  end-page: 257
  ident: CR256
  article-title: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the national epidemiologic survey on alcohol and related conditions
  publication-title: J. Clin. Psychiatry
  doi: 10.4088/JCP.v67n0211
– volume: 16
  start-page: 174
  year: 1997
  end-page: 182
  ident: CR115
  article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(96)00184-4
– volume: 54
  start-page: 71
  year: 1997
  end-page: 80
  ident: CR253
  article-title: Psychiatric and substance use comorbidity among treatment-seeking opioid abusers
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.1997.01830130077015
– volume: 33
  start-page: 221
  year: 2007
  end-page: 228
  ident: CR327
  article-title: What is recovery? A working definition from the Betty Ford institute
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2007.06.001
– volume: 26
  start-page: 5894
  year: 2006
  end-page: 5900
  ident: CR136
  article-title: Conditioned withdrawal drives heroin consumption and decreases reward sensitivity
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0740-06.2006
– volume: 70
  start-page: 785
  year: 2011
  end-page: 793
  ident: CR138
  article-title: The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2011.05.025
– volume: 69
  start-page: 973
  year: 2012
  end-page: 981
  ident: CR308
  article-title: Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2012.1a
– volume: 9
  start-page: CD012021
  year: 2017
  ident: CR216
  article-title: Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
  publication-title: Cochrane Database Syst. Rev.
– volume: 102
  start-page: 1472
  year: 2007
  end-page: 1482
  ident: CR11
  article-title: HIV risk behavior among injection drug users in Tehran, Iran
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.01914.x
– volume: 3
  start-page: CD002024
  year: 2016
  ident: CR268
  article-title: Alpha2-adrenergic agonists for the management of opioid withdrawal
  publication-title: Cochrane Database Syst. Rev.
– volume: 221
  start-page: 227
  year: 1992
  end-page: 234
  ident: CR114
  article-title: Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/0014-2999(92)90706-A
– volume: 35
  start-page: 253
  year: 2003
  end-page: 259
  ident: CR265
  article-title: The clinical opiate withdrawal scale (COWS)
  publication-title: J. Psychoact. Drugs
  doi: 10.1080/02791072.2003.10400007
– volume: 15
  start-page: 266
  year: 2018
  end-page: 275
  ident: CR251
  article-title: Integrated models of care for individuals with opioid use disorder: how do we prevent HIV and HCV?
  publication-title: Curr. HIV/AIDS Rep.
  doi: 10.1007/s11904-018-0396-x
– volume: 255
  start-page: 159
  year: 1975
  end-page: 162
  ident: CR141
  article-title: Morphine abstinence is associated with increased brain cyclic AMP
  publication-title: Nature
  doi: 10.1038/255159b0
– volume: 345
  year: 2012
  ident: CR214
  article-title: Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
  publication-title: BMJ
  doi: 10.1136/bmj.e5945
– volume: 21
  start-page: 608
  year: 2016
  end-page: 614
  ident: CR150
  article-title: Evidence of CNIH3 involvement in opioid dependence
  publication-title: Mol. Psychiatry
  doi: 10.1038/mp.2015.102
– volume: 20
  start-page: 6
  year: 2011
  end-page: 38
  ident: CR67
  article-title: A rapid systematic review on the association between childhood physical and sexual abuse and illicit drug use among males
  publication-title: Child Abuse Rev.
  doi: 10.1002/car.1100
– volume: 180
  start-page: 431
  year: 2017
  end-page: 438
  ident: CR382
  article-title: Building abstinent networks is an important resource in improving quality of life
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2017.09.006
– volume: 85
  start-page: 78
  year: 2018
  end-page: 83
  ident: CR366
  article-title: The Los Angeles county hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in los angeles county (2010-2015)
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2017.02.011
– volume: 1
  start-page: 929
  year: 1978
  end-page: 930
  ident: CR271
  article-title: Clonidine in opiate withdrawal
  publication-title: Lancet
  doi: 10.1016/S0140-6736(78)90699-2
– volume: 65
  start-page: 837
  year: 2016
  end-page: 843
  ident: CR76
  article-title: Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths — 27 states, 2013–2014
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm6533a2
– volume: 189
  start-page: E659
  year: 2017
  end-page: E666
  ident: CR196
  article-title: Guideline for opioid therapy and chronic noncancer pain
  publication-title: CMAJ
  doi: 10.1503/cmaj.170363
– volume: 4
  start-page: e81
  year: 2019
  end-page: e82
  ident: CR350
  article-title: The opioid death crisis in Canada: crucial lessons for public health
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(18)30232-9
– volume: 327
  start-page: 310
  year: 2003
  ident: CR298
  article-title: Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials
  publication-title: BMJ
  doi: 10.1136/bmj.327.7410.310
– ident: CR208
– volume: 145
  start-page: 48
  year: 2014
  end-page: 68
  ident: CR242
  article-title: Supervised injection services: what has been demonstrated? A systematic literature review
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.10.012
– ident: CR195
– volume: 16
  start-page: 107
  year: 1986
  end-page: 122
  ident: CR340
  article-title: Addiction careers: etiology , treatment, and 12-year follow-up outcomes
  publication-title: J. Drug. Issues
  doi: 10.1177/002204268601600106
– volume: 66
  start-page: 88
  year: 2009
  end-page: 94
  ident: CR137
  article-title: Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2008.509
– volume: 40
  start-page: 304
  year: 2014
  end-page: 311
  ident: CR255
  article-title: Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity
  publication-title: Am. J. Drug Alcohol Abuse
  doi: 10.3109/00952990.2014.910519
– ident: CR64
– volume: 295
  start-page: 1
  year: 1991
  end-page: 42
  ident: CR111
  article-title: Piecing together the puzzle of basal forebrain anatomy
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-1-4757-0145-6_1
– volume: 19
  year: 2019
  ident: CR199
  article-title: The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review
  publication-title: BMC Health Serv. Res.
  doi: 10.1186/s12913-019-4642-8
– volume: 19
  start-page: 111
  year: 2014
  end-page: 121
  ident: CR35
  article-title: Association of polymorphisms with heroin dependence in a large case-control series
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2012.00445.x
– volume: 377
  start-page: 2306
  year: 2017
  end-page: 2309
  ident: CR203
  article-title: Coupling policymaking with evaluation - the case of the opioid crisis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp1710014
– ident: CR194
– volume: 318
  start-page: 2174
  year: 2017
  end-page: 2174
  ident: CR17
  article-title: Illicit fentanyl driving opioid overdose deaths
  publication-title: JAMA
– volume: 361
  start-page: 662
  year: 2003
  end-page: 668
  ident: CR258
  article-title: 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)12600-1
– volume: 108
  start-page: 659
  year: 2013
  end-page: 667
  ident: CR70
  article-title: Pathways to heroin dependence: time to re-appraise self-medication
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2012.04001.x
– volume: 379
  start-page: 71
  year: 2012
  end-page: 83
  ident: CR2
  article-title: Drug policy and the public good: evidence for effective interventions
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61674-7
– volume: 43
  start-page: 235
  year: 2014
  end-page: 248
  ident: CR236
  article-title: Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/dyt243
– volume: 54
  start-page: 37
  year: 2015
  end-page: 43
  ident: CR362
  article-title: Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2015.01.009
– volume: 387
  start-page: 1427
  year: 2016
  end-page: 1480
  ident: CR179
  article-title: Public health and international drug policy
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00619-X
– volume: 119
  start-page: 23
  year: 1993
  end-page: 27
  ident: CR276
  article-title: Dose-response effects of methadone in the treatment of opioid dependence
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-119-1-199307010-00004
– volume: 386
  start-page: 350
  year: 2015
  end-page: 359
  ident: CR227
  article-title: Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)62338-2
– volume: 361
  start-page: 777
  year: 2009
  end-page: 786
  ident: CR301
  article-title: Diacetylmorphine versus methadone for the treatment of opioid addiction
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0810635
– volume: 39
  start-page: 30
  year: 2017
  end-page: 46
  ident: CR213
  article-title: Among friends: a qualitative exploration of the role of peers in young people’s alcohol use using Bourdieu’s concepts of habitus, field and capital
  publication-title: Sociol. Health Illn.
  doi: 10.1111/1467-9566.12467
– volume: 37
  start-page: 483
  year: 2017
  end-page: 497
  ident: CR341
  article-title: Estimating state transitions for opioid use disorders
  publication-title: Med. Decis. Mak.
  doi: 10.1177/0272989X16683928
– volume: 127
  start-page: 1
  year: 2007
  end-page: 2
  ident: CR170
  article-title: The amygdala: different pains, different mechanisms
  publication-title: Pain
  doi: 10.1016/j.pain.2006.10.004
– volume: 105
  start-page: 300
  year: 2010
  end-page: 308
  ident: CR303
  article-title: Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2009.02754.x
– volume: 242
  start-page: 715
  year: 1988
  end-page: 723
  ident: CR117
  article-title: Cellular and molecular mechanisms of drug dependence
  publication-title: Science
  doi: 10.1126/science.2903550
– volume: 160
  start-page: 994
  year: 2004
  end-page: 1004
  ident: CR26
  article-title: Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/aje/kwh306
– volume: 66
  start-page: 564
  year: 2005
  end-page: 574
  ident: CR254
  article-title: Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions
  publication-title: J. Clin. Psychiatry
  doi: 10.4088/JCP.v66n0504
– volume: 117
  start-page: 85
  year: 2011
  end-page: 101
  ident: CR7
  article-title: What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2010.11.032
– ident: CR65
– volume: 32
  start-page: 1088
  year: 2007
  end-page: 1093
  ident: CR244
  article-title: Injection drug users’ perceptions regarding use of a medically supervised safer injecting facility
  publication-title: Addict. Behav.
  doi: 10.1016/j.addbeh.2006.07.013
– volume: 65
  start-page: 17
  year: 2016
  end-page: 25
  ident: CR235
  article-title: Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2016.02.007
– volume: 22
  start-page: 5100
  year: 2002
  end-page: 5107
  ident: CR157
  article-title: µ-opioid receptor-mediated antinociceptive responses differ in men and women
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-12-05100.2002
– volume: 343
  start-page: 1291
  year: 2000
  end-page: 1297
  ident: CR287
  article-title: A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM200011023431802
– volume: 23
  start-page: 333
  year: 2012
  end-page: 337
  ident: CR10
  article-title: Transition to injection amongst opioid users in Iran: Implications for harm reduction
  publication-title: Int. J. Drug. Policy
  doi: 10.1016/j.drugpo.2011.09.001
– volume: 83
  start-page: 163
  year: 2006
  end-page: 168
  ident: CR126
  article-title: Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.11.008
– volume: 90
  start-page: 261
  year: 2007
  end-page: 269
  ident: CR286
  article-title: Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100 mg of daily methadone
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2007.04.006
– volume: 113
  start-page: 1461
  year: 2018
  end-page: 1476
  ident: CR234
  article-title: The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom
  publication-title: Addiction
  doi: 10.1111/add.14188
– volume: 132
  start-page: 107
  year: 2013
  end-page: 113
  ident: CR62
  article-title: Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2013.01.010
– volume: 2
  start-page: 901
  year: 2015
  end-page: 908
  ident: CR24
  article-title: Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(15)00366-1
– volume: 28
  start-page: 321
  year: 2005
  end-page: 329
  ident: CR210
  article-title: An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2005.02.007
– volume: 111
  start-page: 391
  year: 2016
  end-page: 407
  ident: CR184
  article-title: Peer-led interventions to prevent tobacco, alcohol and/or drug use among young people aged 11-21 years: a systematic review and meta-analysis
  publication-title: Addiction
  doi: 10.1111/add.13224
– volume: 27
  start-page: 146
  year: 2016
  end-page: 153
  ident: CR381
  article-title: Personal support networks, social capital, and risk of relapse among individuals treated for substance use issues
  publication-title: Int. J. Drug. Policy
  doi: 10.1016/j.drugpo.2015.09.009
– volume: 278
  start-page: 52
  year: 1997
  end-page: 58
  ident: CR90
  article-title: Drug abuse: hedonic homeostatic dysregulation
  publication-title: Science
  doi: 10.1126/science.278.5335.52
– volume: 16
  start-page: 897
  year: 1996
  end-page: 900
  ident: CR140
  article-title: Under siege: the brain on opiates
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)80110-5
– volume: 316
  start-page: 282
  year: 2016
  end-page: 290
  ident: CR289
  article-title: Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2016.9382
– volume: 5
  start-page: 565
  year: 2004
  end-page: 575
  ident: CR104
  article-title: State-dependent opioid control of pain
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn1431
– ident: CR324
– volume: 102
  start-page: 1933
  year: 2007
  end-page: 1941
  ident: CR85
  article-title: Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.01971.x
– volume: 374
  start-page: 154
  year: 2016
  end-page: 163
  ident: CR206
  article-title: Relationship between nonmedical prescription-opioid use and heroin use
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1508490
– year: 2015
  ident: CR295
  article-title: Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2015.03.081
– volume: 93
  start-page: 409
  year: 2000
  end-page: 417
  ident: CR98
  article-title: Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement
  publication-title: Anesthesiology
  doi: 10.1097/00000542-200008000-00019
– volume: 21
  start-page: 1469
  year: 1996
  end-page: 1488
  ident: CR133
  article-title: Opioid receptors: some perspectives from early studies of their role in normal physiology , stress responsivity , and in specific addictive diseases
  publication-title: Neurochem. Res.
  doi: 10.1007/BF02532387
– ident: CR101
– volume: 94
  start-page: 961
  year: 1999
  end-page: 972
  ident: CR176
  article-title: Mechanisms of fatal opioid overdose
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.1999.9479612.x
– ident: CR313
– volume: 94
  start-page: 368
  year: 1994
  end-page: 375
  ident: CR55
  article-title: Parenting behaviors and the onset of smoking and alcohol use: a longitudinal study
  publication-title: Pediatrics
– volume: 33
  start-page: 343
  year: 2009
  end-page: 352
  ident: CR57
  article-title: Child maltreatment as a risk factor for opioid dependence: comparison of family characteristics and type and severity of child maltreatment with a matched control group
  publication-title: Child Abuse Negl.
  doi: 10.1016/j.chiabu.2008.09.009
– ident: CR273
– volume: 14
  start-page: 47
  year: 2000
  end-page: 67
  ident: CR123
  article-title: Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research
  publication-title: Crit. Rev. Neurobiol.
  doi: 10.1615/CritRevNeurobiol.v14.i1.30
– volume: 175
  start-page: 1399
  year: 2006
  end-page: 1404
  ident: CR245
  article-title: Summary of findings from the evaluation of a pilot medically supervised safer injecting facility
  publication-title: CMAJ
  doi: 10.1503/cmaj.060863
– volume: 9
  start-page: CD005031
  year: 2011
  ident: CR263
  article-title: Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
  publication-title: Cochrane Database Syst. Rev.
– volume: 165
  start-page: 159
  year: 2016
  end-page: 167
  ident: CR377
  article-title: Development and validation of ‘sure’: a patient reported outcome measure (prom) for recovery from drug and alcohol dependence
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2016.06.006
– volume: 14
  start-page: 169
  year: 1993
  end-page: 177
  ident: CR125
  article-title: Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers
  publication-title: Synapse
  doi: 10.1002/syn.890140210
– ident: CR312
– volume: 195
  start-page: 1000
  year: 1977
  end-page: 1002
  ident: CR110
  article-title: Conditioned narcotic withdrawal in humans
  publication-title: Science
  doi: 10.1126/science.841320
– volume: 91
  start-page: 102
  year: 2013
  end-page: 123
  ident: CR212
  article-title: Mortality among people who inject drugs: a systematic review and meta-analysis
  publication-title: Bull. World Health Organ.
  doi: 10.2471/BLT.12.108282
– volume: 159
  start-page: 1642
  year: 2002
  end-page: 1652
  ident: CR89
  article-title: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex
  publication-title: Am. J. Psychiatry
  doi: 10.1176/appi.ajp.159.10.1642
– ident: CR94
– volume: 35
  start-page: 217
  year: 2010
  end-page: 238
  ident: CR167
  article-title: Neurocircuitry of addiction
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.110
– volume: 22
  start-page: 496
  year: 1998
  end-page: 519
  ident: CR379
  article-title: Relationships between drug treatment careers and outcomes: findings from the national drug abuse treatment outcome study
  publication-title: Eval. Rev.
  doi: 10.1177/0193841X9802200404
– volume: 18
  year: 2018
  ident: CR197
  article-title: The effects of state rules on opioid prescribing in Indiana
  publication-title: BMC Health Serv. Res.
  doi: 10.1186/s12913-018-2830-6
– volume: 109
  start-page: 1306
  year: 2014
  end-page: 1017
  ident: CR225
  article-title: The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study
  publication-title: Addiction
  doi: 10.1111/add.12536
– ident: CR3
– volume: 391
  start-page: 309
  year: 2018
  end-page: 318
  ident: CR309
  article-title: Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32812-X
– volume: 349
  start-page: 1943
  year: 2003
  end-page: 1953
  ident: CR191
  article-title: Opioid therapy for chronic pain
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra025411
– volume: 28
  start-page: 551
  issue: 3
  year: 1998
  end-page: 558
  ident: CR375
  article-title: Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
  publication-title: Psychological Medicine
  doi: 10.1017/S0033291798006667
– volume: 207
  start-page: 5
  year: 2015
  end-page: 14
  ident: CR302
  article-title: Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction
  publication-title: Br. J. Psychiatry
  doi: 10.1192/bjp.bp.114.149195
– volume: 111
  start-page: 1836
  year: 2016
  end-page: 1847
  ident: CR49
  article-title: Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian mental health survey
  publication-title: Addiction
  doi: 10.1111/add.13453
– volume: 9
  start-page: 466
  year: 2015
  ident: CR154
  article-title: Sex differences in kappa opioid receptor function and their potential impact on addiction
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2015.00466
– ident: CR250
– volume: 2017
  start-page: 397
  year: 2017
  end-page: 476
  ident: CR353
  article-title: Mortality and morbidity in the 21(st) century
  publication-title: Brook. Pap. Econ. Act.
  doi: 10.1353/eca.2017.0005
– volume: 10
  start-page: 782
  year: 1998
  end-page: 785
  ident: CR165
  article-title: Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time
  publication-title: Eur. J. Neurosci.
  doi: 10.1046/j.1460-9568.1998.00083.x
– volume: 20
  start-page: 275
  year: 2015
  end-page: 284
  ident: CR120
  article-title: Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12120
– volume: 28
  start-page: S63
  issue: Suppl. 1
  year: 2005
  end-page: S72
  ident: CR343
  article-title: Pathways in the relapse-treatment-recovery cycle over 3 years
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2004.09.006
– volume: 2
  start-page: 37
  year: 2016
  end-page: 45
  ident: CR148
  article-title: A review of genome-wide association studies of stimulant and opioid use disorders
  publication-title: Mol. Neuropsychiatry
  doi: 10.1159/000444755
– volume: 375
  start-page: 1885
  year: 2010
  end-page: 1895
  ident: CR300
  article-title: Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60349-2
– volume: 6
  start-page: 391
  year: 2019
  end-page: 402
  ident: CR4
  article-title: Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(19)30097-5
– volume: 11
  start-page: 1
  year: 2007
  end-page: 171
  ident: CR219
  article-title: Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation
  publication-title: Health Technol. Assess.
– ident: CR84
– volume: 57
  start-page: 285
  year: 2017
  end-page: 308
  ident: CR124
  article-title: Don’t worry , be happy: endocannabinoids and cannabis at the intersection of stress and reward
  publication-title: Annu. Rev. Pharmacol. Toxicol.
  doi: 10.1146/annurev-pharmtox-010716-104615
– volume: 15
  start-page: 487
  year: 1990
  end-page: 490
  ident: CR264
  article-title: The development of a short opiate withdrawal scale (SOWS)
  publication-title: Addictive Behav.
  doi: 10.1016/0306-4603(90)90036-W
– volume: 122
  start-page: 3387
  year: 2012
  end-page: 3393
  ident: CR19
  article-title: Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI60390
– volume: 35
  start-page: 4296
  year: 2015
  end-page: 4305
  ident: CR121
  article-title: κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1978-13.2015
– volume: 204
  start-page: 107563
  year: 2019
  ident: CR200
  article-title: Evidence for state, community and systems-level prevention strategies to address the opioid crisis
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2019.107563
– volume: 112
  start-page: 1302
  year: 2017
  end-page: 1314
  ident: CR230
  article-title: Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
  publication-title: Addiction
  doi: 10.1111/add.13783
– volume: 28
  start-page: S51
  issue: Suppl. 1
  year: 2005
  end-page: S62
  ident: CR339
  article-title: The duration and correlates of addiction and treatment careers
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2004.10.013
– volume: 3
  year: 2008
  ident: CR243
  article-title: Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0003351
– volume: 33
  start-page: 1318
  year: 2011
  end-page: 1326
  ident: CR139
  article-title: Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response
  publication-title: Eur. J. Neurosci.
  doi: 10.1111/j.1460-9568.2010.07590.x
– volume: 101
  start-page: 1752
  year: 2006
  end-page: 1759
  ident: CR297
  article-title: Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: a randomized controlled trial
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01603.x
– volume: 14
  start-page: 1
  year: 2003
  end-page: 7
  ident: CR159
  article-title: Opioid-induced hyperalgesia: abnormal or normal pain?
  publication-title: Neuroreport
  doi: 10.1097/00001756-200301200-00001
– volume: 132
  start-page: 95
  year: 2013
  end-page: 100
  ident: CR15
  article-title: Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2013.01.007
– volume: 171
  start-page: 39
  year: 2017
  end-page: 49
  ident: CR88
  article-title: A systematic review of injecting-related injury and disease among people who inject drugs
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2016.11.029
– volume: 109
  start-page: 79
  year: 2014
  end-page: 87
  ident: CR363
  article-title: Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
  publication-title: Addiction
  doi: 10.1111/add.12333
– volume: 9
  year: 2013
  ident: CR151
  article-title: Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors
  publication-title: Mol. Pain
  doi: 10.1186/1744-8069-9-45
– volume: 347
  start-page: 237
  year: 1996
  end-page: 240
  ident: CR223
  article-title: Myths about the treatment of addiction
  publication-title: Lancet
  doi: 10.1016/S0140-6736(96)90409-2
– volume: 6
  start-page: 521
  year: 2005
  end-page: 532
  ident: CR143
  article-title: The genetics of addictions: uncovering the genes
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1635
– volume: 98
  start-page: 673
  year: 2003
  end-page: 684
  ident: CR361
  article-title: Does retention matter? Treatment duration and improvement in drug use
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.2003.00354.x
– volume: 133
  start-page: 37
  year: 1976
  end-page: 40
  ident: CR20
  article-title: The natural history of “chipping”
  publication-title: Am. J. Psychiatry
  doi: 10.1176/ajp.133.1.37
– volume: 107
  start-page: 349
  year: 2012
  end-page: 358
  ident: CR31
  article-title: Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2011.03602.x
– volume: 65
  start-page: 1
  year: 2016
  end-page: 49
  ident: CR41
  article-title: CDC guideline for prescribing opioids for chronic pain
  publication-title: MMWR Morb. Mortal. Wkly Rep.
– volume: 50
  start-page: 999-1022
  year: 2010
  ident: CR247
  article-title: What can we learn from the Portuguese decriminalization of illicit drugs?
  publication-title: Br. J. Criminol.
  doi: 10.1093/bjc/azq038
– volume: 65
  start-page: 1445
  year: 2016
  end-page: 1452
  ident: CR349
  article-title: Increases in drug and opioid-involved overdose deaths - United States, 2010-2015
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm655051e1
– volume: 23
  start-page: 3
  year: 2005
  end-page: 15
  ident: CR368
  article-title: Recovery
  publication-title: Alcohol. Treat. Q.
– volume: 5
  start-page: 21
  year: 2011
  end-page: 27
  ident: CR359
  article-title: Adoption and implementation of medications in addiction treatment programs
  publication-title: J. Addict. Med.
  doi: 10.1097/ADM.0b013e3181d41ddb
– volume: 353
  start-page: 221
  year: 1999
  end-page: 226
  ident: CR355
  article-title: Role of maintenance treatment in opioid dependence
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)05356-2
– volume: 49
  start-page: 796
  year: 2015
  end-page: 807
  ident: CR280
  article-title: Drug-drug interactions with antiviral agents in people who inject drugs requiring substitution therapy
  publication-title: Ann. Pharmacother.
  doi: 10.1177/1060028015581848
– volume: 8
  start-page: 176
  year: 2014
  end-page: 182
  ident: CR364
  article-title: A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic
  publication-title: J. Addict. Med.
  doi: 10.1097/ADM.0000000000000035
– volume: 108
  start-page: 377
  year: 2013
  end-page: 384
  ident: CR262
  article-title: A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996-2006
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2012.04066.x
– volume: 30
  start-page: 258
  year: 2011
  end-page: 270
  ident: CR164
  article-title: Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals
  publication-title: J. Addict. Dis.
  doi: 10.1080/10550887.2011.581985
– volume: 157
  start-page: 121
  year: 2015
  end-page: 128
  ident: CR357
  article-title: Short term health-related quality of life improvement during opioid agonist treatment
  publication-title: Drug. Alcohol. Depend.
  doi: 10.1016/j.drugalcdep.2015.10.009
– volume: 112
  start-page: 64
  year: 1992
  end-page: 105
  ident: CR53
  article-title: Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention
  publication-title: Psychological Bull.
  doi: 10.1037/0033-2909.112.1.64
– volume: 24
  start-page: 1334
  year: 2015
  end-page: 1336
  ident: CR77
  article-title: Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis?
  publication-title: Pharmacoepidemiology Drug Saf.
  doi: 10.1002/pds.3901
– volume: 16
  start-page: 1385
  year: 2016
  ident: 137_CR87
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(16)30325-5
– volume: 175
  start-page: 1399
  year: 2006
  ident: 137_CR245
  publication-title: CMAJ
  doi: 10.1503/cmaj.060863
– volume: 374
  start-page: 1232
  year: 2016
  ident: 137_CR336
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1505409
– ident: 137_CR194
– volume: 42
  start-page: 1261
  year: 2012
  ident: 137_CR71
  publication-title: Psychol. Med.
  doi: 10.1017/S0033291711002145
– volume: 341
  start-page: c3172
  year: 2010
  ident: 137_CR30
  publication-title: BMJ
  doi: 10.1136/bmj.c3172
– volume: 110
  start-page: 646
  year: 2015
  ident: 137_CR365
  publication-title: Addiction
  doi: 10.1111/add.12834
– volume: 119
  start-page: 268
  year: 1995
  ident: 137_CR284
  publication-title: Psychopharmacology
  doi: 10.1007/BF02246290
– volume: 19
  year: 2019
  ident: 137_CR199
  publication-title: BMC Health Serv. Res.
  doi: 10.1186/s12913-019-4642-8
– volume: 111
  start-page: 1177
  year: 2016
  ident: 137_CR240
  publication-title: Addiction
  doi: 10.1111/add.13326
– volume: 63
  start-page: 1094
  year: 2016
  ident: 137_CR218
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciw416
– volume: 47
  start-page: 165
  year: 2017
  ident: 137_CR69
  publication-title: J. Appl. Soc. Psychol.
  doi: 10.1111/jasp.12434
– volume: 28
  start-page: 251
  year: 1996
  ident: 137_CR109
  publication-title: J. Psychoact. Drugs
  doi: 10.1080/02791072.1996.10472486
– volume: 108
  start-page: 1296
  year: 2013
  ident: 137_CR229
  publication-title: Addiction
  doi: 10.1111/add.12107
– volume: 22
  start-page: 5100
  year: 2002
  ident: 137_CR157
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-12-05100.2002
– volume: 14
  start-page: 47
  year: 2000
  ident: 137_CR123
  publication-title: Crit. Rev. Neurobiol.
  doi: 10.1615/CritRevNeurobiol.v14.i1.30
– volume: 73
  start-page: 447
  year: 2016
  ident: 137_CR304
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2016.0109
– volume: 10
  start-page: 1225
  year: 2017
  ident: 137_CR278
  publication-title: J. Pain. Res.
  doi: 10.2147/JPR.S138698
– volume: 13
  start-page: 18
  year: 2018
  ident: 137_CR334
  publication-title: Addict. Sci. Clin. Pract.
  doi: 10.1186/s13722-018-0117-1
– volume: 288
  start-page: 1769
  year: 2000
  ident: 137_CR171
  publication-title: Science
  doi: 10.1126/science.288.5472.1769
– volume: 347
  start-page: 237
  year: 1996
  ident: 137_CR223
  publication-title: Lancet
  doi: 10.1016/S0140-6736(96)90409-2
– volume: 114
  start-page: 1602
  year: 2019
  ident: 137_CR202
  publication-title: Addiction
  doi: 10.1111/add.14664
– volume: 374
  start-page: 154
  year: 2016
  ident: 137_CR206
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1508490
– volume: 77
  start-page: 772
  year: 2016
  ident: 137_CR34
  publication-title: J. Clin. Psychiatry
  doi: 10.4088/JCP.15m10386
– volume: 189
  start-page: 1
  year: 2015
  ident: 137_CR12
  publication-title: NCHS Data Brief
– volume: 127
  start-page: 1
  year: 2007
  ident: 137_CR170
  publication-title: Pain
  doi: 10.1016/j.pain.2006.10.004
– volume: 6
  start-page: 639
  year: 2019
  ident: 137_CR352
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(19)30209-3
– volume: 19
  start-page: 111
  year: 2014
  ident: 137_CR35
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2012.00445.x
– volume: 154
  start-page: 230
  year: 2001
  ident: 137_CR285
  publication-title: Psychopharmacology
  doi: 10.1007/s002130000637
– ident: 137_CR101
– volume: 4
  start-page: e81
  year: 2019
  ident: 137_CR350
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(18)30232-9
– volume: 112
  start-page: 605
  year: 2002
  ident: 137_CR173
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(02)00105-7
– volume: 391
  start-page: 266
  year: 2018
  ident: 137_CR189
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)31959-1
– volume: 369
  start-page: 1047
  year: 2007
  ident: 137_CR18
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60464-4
– volume: 75
  start-page: 999
  year: 2014
  ident: 137_CR367
  publication-title: J. Stud. Alcohol. Drugs
  doi: 10.15288/jsad.2014.75.999
– ident: 137_CR273
– volume: 33
  start-page: 13
  year: 2014
  ident: 137_CR369
  publication-title: Drug Alcohol Rev.
  doi: 10.1111/dar.12092
– volume: 189
  start-page: E659
  year: 2017
  ident: 137_CR196
  publication-title: CMAJ
  doi: 10.1503/cmaj.170363
– volume: 133
  start-page: 37
  year: 1976
  ident: 137_CR20
  publication-title: Am. J. Psychiatry
  doi: 10.1176/ajp.133.1.37
– volume: 341
  start-page: c5475
  year: 2010
  ident: 137_CR233
  publication-title: BMJ
  doi: 10.1136/bmj.c5475
– volume: 22
  start-page: 241
  year: 1999
  ident: 137_CR153
  publication-title: Psychiatr. Clin. North Am.
  doi: 10.1016/S0193-953X(05)70074-5
– volume: 113
  start-page: 545
  year: 2018
  ident: 137_CR215
  publication-title: Addiction
  doi: 10.1111/add.14012
– ident: 137_CR3
  doi: 10.1093/oso/9780198818014.001.0001
– volume: 2
  start-page: 37
  year: 2016
  ident: 137_CR148
  publication-title: Mol. Neuropsychiatry
  doi: 10.1159/000444755
– volume: 2017
  start-page: 397
  year: 2017
  ident: 137_CR353
  publication-title: Brook. Pap. Econ. Act.
  doi: 10.1353/eca.2017.0005
– volume: 156
  start-page: 842
  year: 1999
  ident: 137_CR156
  publication-title: Am. J. Psychiatry
  doi: 10.1176/ajp.156.6.842
– volume: 100
  start-page: 1101
  year: 2005
  ident: 137_CR293
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.001128.x
– volume: 108
  start-page: 1675
  year: 2018
  ident: 137_CR5
  publication-title: Am. J. Public Health
  doi: 10.2105/AJPH.2018.304673
– volume: 109
  start-page: 90
  year: 2014
  ident: 137_CR346
  publication-title: Addiction
  doi: 10.1111/add.12337
– volume: 204
  start-page: 107563
  year: 2019
  ident: 137_CR200
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2019.107563
– volume: 353
  start-page: 221
  year: 1999
  ident: 137_CR355
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)05356-2
– volume: 161
  start-page: 202
  year: 2002
  ident: 137_CR275
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-002-1027-0
– volume: 393
  start-page: 1760
  year: 2019
  ident: 137_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)33078-2
– volume: 149
  start-page: 115
  year: 2000
  ident: 137_CR134
  publication-title: Psychopharmacology
  doi: 10.1007/s002139900358
– volume: 9
  start-page: CD012021
  year: 2017
  ident: 137_CR216
  publication-title: Cochrane Database Syst. Rev.
– volume: 96
  start-page: 167
  year: 2008
  ident: 137_CR52
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2008.03.003
– volume: 122
  start-page: 3387
  year: 2012
  ident: 137_CR19
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI60390
– volume: 18
  start-page: 381
  year: 2009
  ident: 137_CR25
  publication-title: Stat. Methods Med. Res.
  doi: 10.1177/0962280208094704
– volume: 31
  start-page: 199
  year: 2012
  ident: 137_CR326
  publication-title: J. Addict. Dis.
  doi: 10.1080/10550887.2012.694597
– year: 2019
  ident: 137_CR192
  publication-title: Ann. Emerg. Med.
  doi: 10.1016/j.annemergmed.2019.07.014
– ident: 137_CR65
– volume: 25
  start-page: 297
  year: 2006
  ident: 137_CR187
  publication-title: Drug. Alcohol. Rev.
  doi: 10.1080/09595230600741024
– volume: 83
  start-page: 163
  year: 2006
  ident: 137_CR126
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.11.008
– volume: 47
  start-page: 293
  year: 2014
  ident: 137_CR371
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2014.05.006
– volume: 11
  start-page: 315
  year: 2017
  ident: 137_CR345
  publication-title: J. Addict. Med.
  doi: 10.1097/ADM.0000000000000312
– volume: 16
  start-page: 633
  year: 2015
  ident: 137_CR50
  publication-title: Prev. Sci.
  doi: 10.1007/s11121-014-0514-y
– volume: 6
  start-page: 391
  year: 2019
  ident: 137_CR4
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(19)30097-5
– volume: 132
  start-page: 107
  year: 2013
  ident: 137_CR62
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2013.01.010
– volume: 52
  start-page: 157
  year: 1990
  ident: 137_CR58
  publication-title: J. Marriage Family
  doi: 10.2307/352847
– volume: 113
  start-page: 1461
  year: 2018
  ident: 137_CR234
  publication-title: Addiction
  doi: 10.1111/add.14188
– volume: 111
  start-page: 695
  year: 2016
  ident: 137_CR288
  publication-title: Addiction
  doi: 10.1111/add.13238
– volume: 361
  start-page: 662
  year: 2003
  ident: 137_CR258
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)12600-1
– volume: 119
  start-page: 23
  year: 1993
  ident: 137_CR276
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-119-1-199307010-00004
– volume: 91
  start-page: 102
  year: 2013
  ident: 137_CR212
  publication-title: Bull. World Health Organ.
  doi: 10.2471/BLT.12.108282
– volume: 31
  start-page: 2692
  year: 2006
  ident: 137_CR95
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301008
– volume: 31
  start-page: 64
  year: 2007
  ident: 137_CR323
  publication-title: Alcohol Clin. Exp. Res.
  doi: 10.1111/j.1530-0277.2006.00273.x
– year: 2019
  ident: 137_CR283
  publication-title: J. Child Adolesc. Psychopharmacol.
  doi: 10.1089/cap.2019.0009
– volume: 361
  year: 2018
  ident: 137_CR186
  publication-title: Science
  doi: 10.1126/science.aau1184
– volume: 158
  start-page: 833
  year: 2017
  ident: 137_CR201
  publication-title: Pain
  doi: 10.1097/j.pain.0000000000000837
– volume: 30
  start-page: 258
  year: 2011
  ident: 137_CR164
  publication-title: J. Addict. Dis.
  doi: 10.1080/10550887.2011.581985
– volume: 142
  start-page: 33
  year: 2014
  ident: 137_CR337
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.05.011
– volume: 5
  start-page: 253
  year: 2014
  ident: 137_CR102
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2014.00253
– volume: 191
  start-page: 55
  year: 2007
  ident: 137_CR299
  publication-title: Br. J. Psychiatry
  doi: 10.1192/bjp.bp.106.026112
– volume: 2
  start-page: 137
  year: 2005
  ident: 137_CR155
  publication-title: Gend. Med.
  doi: 10.1016/S1550-8579(05)80042-7
– volume: 31
  start-page: 548
  year: 2007
  ident: 137_CR32
  publication-title: Eval. Rev.
  doi: 10.1177/0193841X07307315
– volume: 105
  start-page: 300
  year: 2010
  ident: 137_CR303
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2009.02754.x
– volume: 94
  start-page: 368
  year: 1994
  ident: 137_CR55
  publication-title: Pediatrics
  doi: 10.1542/peds.94.3.368
– volume: 93
  start-page: 409
  year: 2000
  ident: 137_CR98
  publication-title: Anesthesiology
  doi: 10.1097/00000542-200008000-00019
– volume: 207
  start-page: 5
  year: 2015
  ident: 137_CR302
  publication-title: Br. J. Psychiatry
  doi: 10.1192/bjp.bp.114.149195
– volume: 111
  start-page: 1836
  year: 2016
  ident: 137_CR49
  publication-title: Addiction
  doi: 10.1111/add.13453
– volume: 278
  start-page: 52
  year: 1997
  ident: 137_CR90
  publication-title: Science
  doi: 10.1126/science.278.5335.52
– volume: 27
  start-page: 633
  year: 2001
  ident: 137_CR330
  publication-title: Am. J. Drug Alcohol Abuse
  doi: 10.1081/ADA-100107660
– volume: 5
  start-page: 21
  year: 2011
  ident: 137_CR359
  publication-title: J. Addict. Med.
  doi: 10.1097/ADM.0b013e3181d41ddb
– volume: 25
  start-page: 307
  year: 2006
  ident: 137_CR188
  publication-title: Drug. Alcohol. Rev.
  doi: 10.1080/09595230600741040
– volume: 316
  start-page: 282
  year: 2016
  ident: 137_CR289
  publication-title: JAMA
  doi: 10.1001/jama.2016.9382
– volume: 76
  start-page: 66
  year: 2014
  ident: 137_CR149
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2013.08.034
– volume: 16
  start-page: 174
  year: 1997
  ident: 137_CR115
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(96)00184-4
– ident: 137_CR93
– volume: 78
  start-page: 474
  year: 2015
  ident: 137_CR146
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2015.01.003
– volume: 28
  start-page: S51
  issue: Suppl. 1
  year: 2005
  ident: 137_CR339
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2004.10.013
– ident: 137_CR174
  doi: 10.1176/appi.books.9780890425596
– volume: 112
  start-page: 1784
  year: 2017
  ident: 137_CR198
  publication-title: Addiction
  doi: 10.1111/add.13860
– ident: 137_CR207
– volume: 70
  start-page: 785
  year: 2011
  ident: 137_CR138
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2011.05.025
– volume: 132
  start-page: 128
  year: 2012
  ident: 137_CR182
  publication-title: Perspect. Public Health
  doi: 10.1177/1757913912443487
– volume: 103
  start-page: 251
  year: 2008
  ident: 137_CR261
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.02081.x
– volume: 63
  start-page: 102
  year: 2006
  ident: 137_CR321
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.63.1.102
– volume: 23
  start-page: 76
  year: 2015
  ident: 137_CR342
  publication-title: Harv. Rev. Psychiatry
  doi: 10.1097/HRP.0000000000000052
– volume: 57
  start-page: 285
  year: 2017
  ident: 137_CR124
  publication-title: Annu. Rev. Pharmacol. Toxicol.
  doi: 10.1146/annurev-pharmtox-010716-104615
– volume: 101
  start-page: 181
  year: 2006
  ident: 137_CR226
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01316.x
– ident: 137_CR386
– volume: 35
  start-page: 4296
  year: 2015
  ident: 137_CR121
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1978-13.2015
– volume: 94
  start-page: 961
  year: 1999
  ident: 137_CR176
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.1999.9479612.x
– volume: 33
  start-page: 1122
  year: 1994
  ident: 137_CR56
  publication-title: J. Am. Acad. Child Adolesc. Psychiatry
  doi: 10.1097/00004583-199410000-00008
– volume: 87
  start-page: 1644
  year: 2016
  ident: 137_CR190
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00161-6
– volume: 178
  start-page: 861
  year: 2018
  ident: 137_CR42
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2018.1999
– volume: 89
  start-page: 1379
  year: 2009
  ident: 137_CR97
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00005.2009
– volume: 28
  start-page: 32
  year: 2004
  ident: 137_CR335
  publication-title: Aust. N. Z. J. Public. Health
  doi: 10.1111/j.1467-842X.2004.tb00629.x
– volume: 10
  start-page: 295
  year: 2007
  ident: 137_CR61
  publication-title: Clin. Child Family Psychol. Rev.
  doi: 10.1007/s10567-007-0023-7
– volume: 3
  start-page: CD002024
  year: 2016
  ident: 137_CR268
  publication-title: Cochrane Database Syst. Rev.
– volume: 29
  start-page: 14764
  year: 2009
  ident: 137_CR163
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4291-09.2009
– volume: 166
  start-page: 26
  year: 2016
  ident: 137_CR162
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2016.06.024
– volume: 316
  start-page: 426
  year: 1998
  ident: 137_CR260
  publication-title: BMJ
  doi: 10.1136/bmj.316.7129.426
– volume: 66
  start-page: 825
  year: 2009
  ident: 137_CR281
  publication-title: Am. J. Health Syst. Pharm.
  doi: 10.2146/ajhp070392
– volume: 233
  start-page: 1991
  year: 2016
  ident: 137_CR129
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-015-4060-5
– volume: 5
  start-page: CD004147
  year: 2011
  ident: 137_CR317
  publication-title: Cochrane Database Syst. Rev.
– volume: 5
  start-page: 565
  year: 2004
  ident: 137_CR104
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn1431
– volume: 19
  start-page: 375
  year: 2000
  ident: 137_CR331
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/S0740-5472(00)00124-0
– ident: 137_CR47
– volume: 165
  start-page: 31
  year: 1996
  ident: 137_CR175
  publication-title: West. J. Med.
– volume: 90
  start-page: 261
  year: 2007
  ident: 137_CR286
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2007.04.006
– year: 2015
  ident: 137_CR295
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2015.03.081
– volume: 179
  start-page: 291
  year: 2017
  ident: 137_CR351
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2017.07.018
– volume: 21
  start-page: 364
  year: 2010
  ident: 137_CR376
  publication-title: Int. J. Drug. Policy
  doi: 10.1016/j.drugpo.2010.01.010
– volume: 89
  start-page: 631
  year: 1999
  ident: 137_CR99
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(98)00652-6
– volume: 15
  start-page: 829
  year: 1941
  ident: 137_CR266
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-15-5-829
– volume: 41
  start-page: 373
  year: 2016
  ident: 137_CR122
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2015.258
– volume: 4
  year: 2014
  ident: 137_CR228
  publication-title: BMJ Open.
  doi: 10.1136/bmjopen-2013-004666
– volume: 21
  start-page: 74
  year: 2013
  ident: 137_CR306
  publication-title: Exp. Clin. Psychopharmacol.
  doi: 10.1037/a0030743
– volume: 33
  start-page: 13
  year: 2000
  ident: 137_CR131
  publication-title: Brain Res. Rev.
  doi: 10.1016/S0165-0173(00)00024-2
– volume: 112
  start-page: 1408
  year: 2017
  ident: 137_CR224
  publication-title: Addiction
  doi: 10.1111/add.13779
– volume: 46
  start-page: 136
  year: 2017
  ident: 137_CR78
  publication-title: Int. J. Drug Policy
  doi: 10.1016/j.drugpo.2017.05.023
– volume: 36
  start-page: 195
  year: 2013
  ident: 137_CR92
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2012.11.002
– volume: 195
  start-page: 1000
  year: 1977
  ident: 137_CR110
  publication-title: Science
  doi: 10.1126/science.841320
– volume: 390
  start-page: 1211
  year: 2017
  ident: 137_CR8
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32154-2
– ident: 137_CR45
– volume: 387
  start-page: 1427
  year: 2016
  ident: 137_CR179
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00619-X
– volume: 219
  start-page: 427
  year: 2014
  ident: 137_CR105
  publication-title: Handb. Exp. Pharmacol.
  doi: 10.1007/978-3-642-41199-1_22
– volume: 108
  start-page: 79
  year: 1992
  ident: 137_CR127
  publication-title: Psychopharmacology
  doi: 10.1007/BF02245289
– volume: 357
  start-page: j1550
  year: 2017
  ident: 137_CR22
  publication-title: BMJ
  doi: 10.1136/bmj.j1550
– volume: 64
  start-page: 453
  year: 2015
  ident: 137_CR82
  publication-title: MMWR Morb. Mortal. Wkly Rep.
– volume: 11
  start-page: 1092
  year: 2010
  ident: 137_CR169
  publication-title: Pain Med.
  doi: 10.1111/j.1526-4637.2010.00881.x
– volume: 65
  start-page: 837
  year: 2016
  ident: 137_CR76
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm6533a2
– volume: 33
  start-page: 229
  year: 2007
  ident: 137_CR325
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2007.04.015
– volume: 23
  start-page: 559
  year: 2013
  ident: 137_CR384
  publication-title: Curr. Opin. Neurobiol.
  doi: 10.1016/j.conb.2013.03.011
– volume: 171
  start-page: 1165
  year: 2017
  ident: 137_CR107
  publication-title: Cell
  doi: 10.1016/j.cell.2017.10.035
– ident: 137_CR250
– volume: 39
  start-page: 121
  year: 2017
  ident: 137_CR248
  publication-title: Int. J. Drug Policy
  doi: 10.1016/j.drugpo.2016.10.014
– volume: 10
  start-page: 782
  year: 1998
  ident: 137_CR165
  publication-title: Eur. J. Neurosci.
  doi: 10.1046/j.1460-9568.1998.00083.x
– volume: 7
  start-page: 289
  year: 1986
  ident: 137_CR185
  publication-title: Crime Justice
  doi: 10.1086/449116
– ident: 137_CR324
  doi: 10.1017/CBO9780511543883
– volume: 394
  start-page: 1560
  year: 2019
  ident: 137_CR38
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)32229-9
– volume: 94
  start-page: 199
  year: 1999
  ident: 137_CR237
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.1999.9421993.x
– volume: 35
  start-page: 253
  year: 2003
  ident: 137_CR265
  publication-title: J. Psychoact. Drugs
  doi: 10.1080/02791072.2003.10400007
– ident: 137_CR6
– volume: 1
  start-page: 232
  year: 1996
  ident: 137_CR132
  publication-title: Mol. Psychiatry
– volume: 16
  start-page: 1013
  year: 2005
  ident: 137_CR130
  publication-title: Neuroreport
  doi: 10.1097/00001756-200506210-00026
– volume: 349
  start-page: 1943
  year: 2003
  ident: 137_CR191
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra025411
– volume: 15
  start-page: 580
  year: 2015
  ident: 137_CR147
  publication-title: Pain Pract.
  doi: 10.1111/papr.12232
– volume: 106
  start-page: 2186
  year: 2011
  ident: 137_CR178
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2011.03575.x
– volume: 11
  start-page: 1
  year: 2007
  ident: 137_CR219
  publication-title: Health Technol. Assess.
– volume: 318
  start-page: 2174
  year: 2017
  ident: 137_CR17
  publication-title: JAMA
– volume: 35
  start-page: 217
  year: 2010
  ident: 137_CR167
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.110
– volume: 9
  start-page: 466
  year: 2015
  ident: 137_CR154
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2015.00466
– volume: 22
  start-page: 496
  year: 1998
  ident: 137_CR379
  publication-title: Eval. Rev.
  doi: 10.1177/0193841X9802200404
– volume: 25
  start-page: 177
  year: 2003
  ident: 137_CR380
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/S0740-5472(03)00125-9
– volume: 133
  start-page: 633
  year: 2013
  ident: 137_CR322
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2013.08.006
– volume: 79
  start-page: 434
  year: 2002
  ident: 137_CR180
  publication-title: J. Urban Health
  doi: 10.1093/jurban/79.3.434
– volume: 180
  start-page: 431
  year: 2017
  ident: 137_CR382
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2017.09.006
– ident: 137_CR46
– ident: 137_CR80
– volume: 372
  start-page: 241
  year: 2015
  ident: 137_CR13
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMsa1406143
– volume: 28
  start-page: 3861
  year: 2008
  ident: 137_CR166
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0227-08.2008
– volume: 295
  start-page: 1
  year: 1991
  ident: 137_CR111
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-1-4757-0145-6_1
– volume: 6
  start-page: 44
  year: 2011
  ident: 137_CR373
  publication-title: Addict. Sci. Clin. Pract.
– volume: 16
  start-page: 1745
  year: 2015
  ident: 137_CR59
  publication-title: Pain. Med.
  doi: 10.1111/pme.12773
– volume: 753
  start-page: 73
  year: 2015
  ident: 137_CR112
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2014.11.044
– volume: 108
  start-page: 743
  year: 2013
  ident: 137_CR66
  publication-title: Addiction
  doi: 10.1111/add.12056
– volume: 2015
  start-page: 368979
  year: 2015
  ident: 137_CR145
  publication-title: Int. J. Genomics
  doi: 10.1155/2015/368979
– volume: 108
  start-page: 659
  year: 2013
  ident: 137_CR70
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2012.04001.x
– volume: 377
  start-page: 1506
  year: 2011
  ident: 137_CR307
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60358-9
– volume: 65
  start-page: 1
  year: 2016
  ident: 137_CR41
  publication-title: MMWR Morb. Mortal. Wkly Rep.
– volume: 47
  start-page: 149
  year: 2015
  ident: 137_CR356
  publication-title: J. Psychoact. Drugs
  doi: 10.1080/02791072.2015.1014948
– volume: 8
  start-page: 176
  year: 2014
  ident: 137_CR364
  publication-title: J. Addict. Med.
  doi: 10.1097/ADM.0000000000000035
– volume: 145
  start-page: 48
  year: 2014
  ident: 137_CR242
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.10.012
– volume: 23
  start-page: 238
  year: 2017
  ident: 137_CR374
  publication-title: Eur. Addict. Res.
  doi: 10.1159/000484239
– volume: 85
  start-page: 78
  year: 2018
  ident: 137_CR366
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2017.02.011
– volume: 83
  start-page: S4
  year: 2006
  ident: 137_CR48
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.10.020
– volume: 113
  start-page: 173
  year: 2018
  ident: 137_CR231
  publication-title: Addiction
  doi: 10.1111/add.13948
– start-page: e218
  volume-title: Lancet Public Health
  year: 2018
  ident: 137_CR241
– volume: 221
  start-page: 227
  year: 1992
  ident: 137_CR114
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/0014-2999(92)90706-A
– volume: 374
  start-page: 1253
  year: 2016
  ident: 137_CR108
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1507771
– volume: 26
  start-page: 5894
  year: 2006
  ident: 137_CR136
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0740-06.2006
– volume: 290
  start-page: 78
  year: 2004
  ident: 137_CR142
  publication-title: Sci. Am.
  doi: 10.1038/scientificamerican0304-78
– volume: 33
  start-page: 343
  year: 2009
  ident: 137_CR57
  publication-title: Child Abuse Negl.
  doi: 10.1016/j.chiabu.2008.09.009
– volume: 255
  start-page: 159
  year: 1975
  ident: 137_CR141
  publication-title: Nature
  doi: 10.1038/255159b0
– volume: 18
  year: 2018
  ident: 137_CR197
  publication-title: BMC Health Serv. Res.
  doi: 10.1186/s12913-018-2830-6
– volume: 32
  start-page: 1088
  year: 2007
  ident: 137_CR244
  publication-title: Addict. Behav.
  doi: 10.1016/j.addbeh.2006.07.013
– ident: 137_CR314
– ident: 137_CR291
– volume: 327
  start-page: 310
  year: 2003
  ident: 137_CR298
  publication-title: BMJ
  doi: 10.1136/bmj.327.7410.310
– volume: 10
  start-page: 561
  year: 2009
  ident: 137_CR128
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn2515
– volume: 2
  year: 2019
  ident: 137_CR43
  publication-title: JAMA Netw. Open.
  doi: 10.1001/jamanetworkopen.2018.6007
– volume: 108
  start-page: 182
  year: 2018
  ident: 137_CR72
  publication-title: Am. J. Public Health
  doi: 10.2105/AJPH.2017.304187
– volume: 73
  start-page: 568
  year: 1995
  ident: 137_CR172
  publication-title: J. Neurophysiol.
  doi: 10.1152/jn.1995.73.2.568
– volume: 14
  start-page: 169
  year: 1993
  ident: 137_CR125
  publication-title: Synapse
  doi: 10.1002/syn.890140210
– ident: 137_CR313
– volume: 20
  start-page: 6
  year: 2011
  ident: 137_CR67
  publication-title: Child Abuse Rev.
  doi: 10.1002/car.1100
– volume: 33
  start-page: 221
  year: 2007
  ident: 137_CR327
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2007.06.001
– volume: 23
  start-page: 281
  year: 1995
  ident: 137_CR60
  publication-title: J. Abnorm. Child Psychol.
  doi: 10.1007/BF01447558
– ident: 137_CR94
  doi: 10.1007/978-1-4684-3426-2
– volume: 26
  start-page: 199
  year: 2015
  ident: 137_CR249
  publication-title: Int. J. Drug Policy
  doi: 10.1016/j.drugpo.2014.08.017
– volume: 284
  start-page: 1689
  year: 2000
  ident: 137_CR222
  publication-title: JAMA
  doi: 10.1001/jama.284.13.1689
– ident: 137_CR84
– volume: 65
  start-page: 1
  year: 2016
  ident: 137_CR36
  publication-title: MMWR Recomm. Rep.
  doi: 10.15585/mmwr.rr6501e1
– volume: 98
  start-page: 427
  year: 2003
  ident: 137_CR269
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.2003.00372.x
– volume: 38
  start-page: 3
  year: 2017
  ident: 137_CR205
  publication-title: Subst. Abus.
  doi: 10.1080/08897077.2016.1261070
– volume: 37
  start-page: 95
  year: 2009
  ident: 137_CR270
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2008.09.007
– volume: 391
  start-page: 309
  year: 2018
  ident: 137_CR309
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32812-X
– volume: 15
  start-page: 266
  year: 2018
  ident: 137_CR251
  publication-title: Curr. HIV/AIDS Rep.
  doi: 10.1007/s11904-018-0396-x
– volume: 69
  start-page: 57
  year: 2016
  ident: 137_CR252
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2016.07.003
– volume: 151
  start-page: 567
  year: 2010
  ident: 137_CR63
  publication-title: Pain
  doi: 10.1016/j.pain.2010.08.036
– volume: 18
  start-page: 22
  year: 1995
  ident: 137_CR91
  publication-title: Trends Neurosci.
  doi: 10.1016/0166-2236(95)93946-U
– volume: 200
  start-page: 34
  year: 2019
  ident: 137_CR311
  publication-title: Drug. Alcohol. Depend.
  doi: 10.1016/j.drugalcdep.2019.02.031
– volume: 318
  start-page: 1065
  year: 2017
  ident: 137_CR348
  publication-title: JAMA.
  doi: 10.1001/jama.2017.9308
– volume: 70
  start-page: 1347
  year: 2013
  ident: 137_CR272
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.2216
– volume: 109
  start-page: 79
  year: 2014
  ident: 137_CR363
  publication-title: Addiction
  doi: 10.1111/add.12333
– ident: 137_CR152
– volume: 28
  start-page: S63
  issue: Suppl. 1
  year: 2005
  ident: 137_CR343
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2004.09.006
– volume: 5
  start-page: e1192
  year: 2017
  ident: 137_CR86
  publication-title: Lancet Glob. Health
  doi: 10.1016/S2214-109X(17)30375-3
– volume: 131
  start-page: 823
  year: 2012
  ident: 137_CR144
  publication-title: Hum. Genet.
  doi: 10.1007/s00439-012-1172-4
– volume: 27
  start-page: 146
  year: 2016
  ident: 137_CR381
  publication-title: Int. J. Drug. Policy
  doi: 10.1016/j.drugpo.2015.09.009
– volume: 79
  start-page: 1395
  issue: 13
  year: 2019
  ident: 137_CR332
  publication-title: Drugs
  doi: 10.1007/s40265-019-01154-5
– volume: 74
  start-page: 445
  year: 2017
  ident: 137_CR16
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2017.0113
– volume: 386
  start-page: 350
  year: 2015
  ident: 137_CR227
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)62338-2
– volume: 16
  start-page: 1323
  year: 2016
  ident: 137_CR74
  publication-title: Am. J. Transplant.
  doi: 10.1111/ajt.13776
– volume: 79
  start-page: 231
  year: 2005
  ident: 137_CR28
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.01.013
– year: 2011
  ident: 137_CR318
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.121
– ident: 137_CR246
– volume: 12
  start-page: CD003020
  year: 2014
  ident: 137_CR181
  publication-title: Cochrane Database Syst. Rev.
– volume: 28
  start-page: 286
  year: 1973
  ident: 137_CR100
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.1973.01750320112017
– volume: 39
  start-page: 1968
  year: 2014
  ident: 137_CR103
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.45
– volume: 6
  start-page: 95
  year: 2017
  ident: 137_CR358
  publication-title: J. Educ. Health Promot
  doi: 10.4103/jehp.jehp_297_13
– volume: 15
  start-page: 487
  year: 1990
  ident: 137_CR264
  publication-title: Addictive Behav.
  doi: 10.1016/0306-4603(90)90036-W
– volume: 178
  start-page: 764
  year: 2018
  ident: 137_CR292
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2018.1052
– volume: 23
  start-page: 31
  year: 2015
  ident: 137_CR378
  publication-title: Drugs Educ. Prev. Policy
  doi: 10.3109/09687637.2015.1100587
– volume: 247
  start-page: 47
  year: 1988
  ident: 137_CR274
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 1
  start-page: 929
  year: 1978
  ident: 137_CR271
  publication-title: Lancet
  doi: 10.1016/S0140-6736(78)90699-2
– volume: 110
  start-page: 1975
  year: 2015
  ident: 137_CR220
  publication-title: Addiction
  doi: 10.1111/add.13073
– volume: 16
  start-page: CD001333
  year: 2011
  ident: 137_CR305
  publication-title: Cochrane Database Syst. Rev.
– volume: 36
  start-page: 559
  year: 2015
  ident: 137_CR40
  publication-title: Annu. Rev. Public Health
  doi: 10.1146/annurev-publhealth-031914-122957
– volume: 14
  start-page: 543
  year: 1997
  ident: 137_CR338
  publication-title: J.Subst. Abuse Treat.
  doi: 10.1016/S0740-5472(97)00016-0
– volume: 159
  start-page: 1642
  year: 2002
  ident: 137_CR89
  publication-title: Am. J. Psychiatry
  doi: 10.1176/appi.ajp.159.10.1642
– volume: 108
  start-page: 377
  year: 2013
  ident: 137_CR262
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2012.04066.x
– volume: 108
  start-page: 65
  year: 2010
  ident: 137_CR333
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2009.11.008
– volume: 167
  start-page: 293
  year: 2017
  ident: 137_CR14
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M17-0865
– volume: 377
  start-page: 2306
  year: 2017
  ident: 137_CR203
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp1710014
– volume: 107
  start-page: 2983
  year: 2018
  ident: 137_CR279
  publication-title: J. Pharm. Sci.
  doi: 10.1016/j.xphs.2018.08.025
– volume: 50
  start-page: 999-1022
  year: 2010
  ident: 137_CR247
  publication-title: Br. J. Criminol.
  doi: 10.1093/bjc/azq038
– volume: 379
  start-page: 71
  year: 2012
  ident: 137_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61674-7
– volume: 16
  start-page: 107
  year: 1986
  ident: 137_CR340
  publication-title: J. Drug. Issues
  doi: 10.1177/002204268601600106
– volume: 67
  start-page: 247
  year: 2006
  ident: 137_CR256
  publication-title: J. Clin. Psychiatry
  doi: 10.4088/JCP.v67n0211
– volume: 107
  start-page: 349
  year: 2012
  ident: 137_CR31
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2011.03602.x
– volume: 174
  start-page: 1947
  year: 2014
  ident: 137_CR257
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2014.5302
– year: 2017
  ident: 137_CR239
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2017.05.001
– volume: 66
  start-page: 1197
  year: 2017
  ident: 137_CR75
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm6643e1
– volume: 63
  start-page: 563
  year: 2014
  ident: 137_CR39
  publication-title: MMWR Morb. Mortal. Wkly Rep.
– volume: 376
  start-page: 285
  year: 2010
  ident: 137_CR33
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60742-8
– volume: 8
  start-page: CD002209
  year: 2009
  ident: 137_CR211
  publication-title: Cochrane Database Syst. Rev
– volume: 109
  start-page: 617
  year: 2014
  ident: 137_CR294
  publication-title: Addiction
  doi: 10.1111/add.12440
– volume: 35
  start-page: 501
  year: 1978
  ident: 137_CR282
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.1978.01770280111012
– ident: 137_CR312
– volume: 4
  start-page: 511
  year: 2003
  ident: 137_CR160
  publication-title: J. Pain
  doi: 10.1016/j.jpain.2003.08.003
– ident: 137_CR64
– volume: 293
  start-page: 103
  year: 1986
  ident: 137_CR267
  publication-title: Br. Med. J.
  doi: 10.1136/bmj.293.6539.103
– volume: 361
  start-page: 777
  year: 2009
  ident: 137_CR301
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0810635
– volume: 16
  start-page: 897
  year: 1996
  ident: 137_CR140
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)80110-5
– volume: 112
  start-page: 64
  year: 1992
  ident: 137_CR53
  publication-title: Psychological Bull.
  doi: 10.1037/0033-2909.112.1.64
– volume: 169
  start-page: 137
  year: 2018
  ident: 137_CR310
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M17-3107
– volume: 102
  start-page: 1933
  year: 2007
  ident: 137_CR85
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.01971.x
– volume: 91
  start-page: 295
  year: 2009
  ident: 137_CR119
  publication-title: Pharmacol. Biochem. Behav.
  doi: 10.1016/j.pbb.2008.07.012
– volume: 43
  start-page: 235
  year: 2014
  ident: 137_CR236
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/dyt243
– volume: 59
  start-page: 1411
  year: 2014
  ident: 137_CR81
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciu643
– volume: 69
  start-page: 973
  year: 2012
  ident: 137_CR308
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2012.1a
– volume: 9
  start-page: CD012880
  year: 2019
  ident: 137_CR329
  publication-title: Cochrane Database Syst. Rev.
– volume: 39
  start-page: 30
  year: 2017
  ident: 137_CR213
  publication-title: Sociol. Health Illn.
  doi: 10.1111/1467-9566.12467
– volume: 54
  start-page: 71
  year: 1997
  ident: 137_CR253
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.1997.01830130077015
– volume: 76
  start-page: 88
  year: 2017
  ident: 137_CR370
  publication-title: J. Substance Abuse Treat.
  doi: 10.1016/j.jsat.2017.01.019
– volume: 22
  start-page: 247
  year: 2001
  ident: 137_CR328
  publication-title: Subst. Abus.
– volume: 66
  start-page: 564
  year: 2005
  ident: 137_CR254
  publication-title: J. Clin. Psychiatry
  doi: 10.4088/JCP.v66n0504
– volume: 109
  start-page: 1306
  year: 2014
  ident: 137_CR225
  publication-title: Addiction
  doi: 10.1111/add.12536
– volume: 65
  start-page: 17
  year: 2016
  ident: 137_CR235
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2016.02.007
– volume: 344
  year: 2012
  ident: 137_CR9
  publication-title: BMJ
  doi: 10.1136/bmj.e2502
– ident: 137_CR195
  doi: 10.3109/15360288.2016.1173761
– volume: 54
  start-page: 37
  year: 2015
  ident: 137_CR362
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2015.01.009
– volume: 117
  start-page: 85
  year: 2011
  ident: 137_CR7
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2010.11.032
– volume: 66
  start-page: 88
  year: 2009
  ident: 137_CR137
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2008.509
– volume: 165
  start-page: 159
  year: 2016
  ident: 137_CR377
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2016.06.006
– volume: 375
  start-page: 1885
  year: 2010
  ident: 137_CR300
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60349-2
– volume: 343
  start-page: 1291
  year: 2000
  ident: 137_CR287
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM200011023431802
– ident: 137_CR208
– volume: 2
  start-page: 901
  year: 2015
  ident: 137_CR24
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(15)00366-1
– volume: 242
  start-page: 715
  year: 1988
  ident: 137_CR117
  publication-title: Science
  doi: 10.1126/science.2903550
– volume: 62
  start-page: 1157
  year: 2005
  ident: 137_CR354
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.62.10.1157
– volume: 25
  start-page: CD004330
  year: 2005
  ident: 137_CR360
  publication-title: Cochrane Database Syst. Rev.
– volume: 345
  year: 2012
  ident: 137_CR214
  publication-title: BMJ
  doi: 10.1136/bmj.e5945
– volume: 24
  start-page: 97
  year: 2001
  ident: 137_CR168
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00195-0
– volume: 108
  start-page: 84
  year: 2010
  ident: 137_CR73
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2009.12.001
– volume: 98
  start-page: 673
  year: 2003
  ident: 137_CR361
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.2003.00354.x
– ident: 137_CR387
  doi: 10.1016/B978-0-12-385870-2.00041-X
– volume: 9
  start-page: CD005031
  year: 2011
  ident: 137_CR263
  publication-title: Cochrane Database Syst. Rev.
– volume: 112
  start-page: 1302
  year: 2017
  ident: 137_CR230
  publication-title: Addiction
  doi: 10.1111/add.13783
– volume: 23
  start-page: 3
  year: 2005
  ident: 137_CR368
  publication-title: Alcohol. Treat. Q.
– volume: 9
  year: 2013
  ident: 137_CR151
  publication-title: Mol. Pain
  doi: 10.1186/1744-8069-9-45
– ident: 137_CR316
– volume: 76
  start-page: 909
  year: 2015
  ident: 137_CR347
  publication-title: J. Stud. Alcohol. Drugs
  doi: 10.15288/jsad.2015.76.909
– volume: 38
  start-page: 265
  year: 2017
  ident: 137_CR44
  publication-title: Subst. Abus.
  doi: 10.1080/08897077.2017.1316812
– volume: 80
  start-page: 267
  year: 2005
  ident: 137_CR296
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.04.007
– volume: 90
  start-page: 91
  year: 2001
  ident: 137_CR161
  publication-title: Pain
  doi: 10.1016/S0304-3959(00)00391-2
– volume: 6
  start-page: 205
  year: 2016
  ident: 137_CR158
  publication-title: Am. J. Nucl. Med. Mol. Imaging
– volume: 57
  start-page: S39
  issue: Suppl. 2
  year: 2013
  ident: 137_CR385
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cit296
– volume: 87
  start-page: 1345
  year: 1992
  ident: 137_CR27
  publication-title: Br. J. Addict.
  doi: 10.1111/j.1360-0443.1992.tb02743.x
– volume: 15
  start-page: 211
  year: 2008
  ident: 137_CR238
  publication-title: Drugs Educ. Prevent. Policy
  doi: 10.1080/09687630701731205
– volume: 3
  year: 2008
  ident: 137_CR243
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0003351
– volume: 2
  start-page: 485
  year: 1979
  ident: 137_CR259
  publication-title: Lancet
  doi: 10.1016/S0140-6736(79)91550-2
– volume: 99
  start-page: 183
  year: 2009
  ident: 137_CR116
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2008.07.012
– volume: 24
  start-page: 152
  year: 2001
  ident: 137_CR135
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00186-X
– volume: 6
  start-page: 521
  year: 2005
  ident: 137_CR143
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1635
– volume: 65
  start-page: 1445
  year: 2016
  ident: 137_CR349
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm655051e1
– volume: 83
  start-page: 147
  year: 2006
  ident: 137_CR29
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.11.007
– volume: 21
  start-page: 608
  year: 2016
  ident: 137_CR150
  publication-title: Mol. Psychiatry
  doi: 10.1038/mp.2015.102
– volume: 134
  start-page: 251
  year: 2014
  ident: 137_CR372
  publication-title: Drug. Alcohol. Depend.
  doi: 10.1016/j.drugalcdep.2013.10.011
– volume: 8
  start-page: 1445
  year: 2005
  ident: 137_CR383
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn1578
– ident: 137_CR315
– volume: 20
  start-page: 275
  year: 2015
  ident: 137_CR120
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12120
– volume: 66
  start-page: 382
  year: 2017
  ident: 137_CR79
  publication-title: MMWR Morb. Mortal. Wkly Rep.
  doi: 10.15585/mmwr.mm6614a2
– ident: 137_CR221
– volume: 315
  start-page: 1624
  year: 2016
  ident: 137_CR37
  publication-title: JAMA
  doi: 10.1001/jama.2016.1464
– volume: 23
  start-page: 333
  year: 2012
  ident: 137_CR10
  publication-title: Int. J. Drug. Policy
  doi: 10.1016/j.drugpo.2011.09.001
– volume: 157
  start-page: 121
  year: 2015
  ident: 137_CR357
  publication-title: Drug. Alcohol. Depend.
  doi: 10.1016/j.drugalcdep.2015.10.009
– ident: 137_CR209
– volume: 100
  start-page: 1496
  year: 2005
  ident: 137_CR277
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.01232.x
– volume: 111
  start-page: 391
  year: 2016
  ident: 137_CR184
  publication-title: Addiction
  doi: 10.1111/add.13224
– ident: 137_CR51
– volume: 40
  start-page: 304
  year: 2014
  ident: 137_CR255
  publication-title: Am. J. Drug Alcohol Abuse
  doi: 10.3109/00952990.2014.910519
– volume: 102
  start-page: 1472
  year: 2007
  ident: 137_CR11
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.01914.x
– volume: 132
  start-page: 95
  year: 2013
  ident: 137_CR15
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2013.01.007
– volume: 33
  start-page: 1318
  year: 2011
  ident: 137_CR139
  publication-title: Eur. J. Neurosci.
  doi: 10.1111/j.1460-9568.2010.07590.x
– volume: 355
  start-page: 365
  year: 2006
  ident: 137_CR319
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa055255
– volume: 58
  start-page: 503
  year: 2001
  ident: 137_CR21
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.58.5.503
– volume: 28
  start-page: 551
  issue: 3
  year: 1998
  ident: 137_CR375
  publication-title: Psychological Medicine
  doi: 10.1017/S0033291798006667
– year: 2016
  ident: 137_CR183
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)00002-X
– volume: 160
  start-page: 994
  year: 2004
  ident: 137_CR26
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/aje/kwh306
– volume: 21
  start-page: 1469
  year: 1996
  ident: 137_CR133
  publication-title: Neurochem. Res.
  doi: 10.1007/BF02532387
– volume: 5
  start-page: e578
  year: 2018
  ident: 137_CR232
  publication-title: Lancet HIV
  doi: 10.1016/S2352-3018(18)30168-1
– volume: 101
  start-page: 1752
  year: 2006
  ident: 137_CR297
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01603.x
– volume: 352
  start-page: i19
  year: 2016
  ident: 137_CR83
  publication-title: BMJ
  doi: 10.1136/bmj.i19
– volume: 105
  start-page: 1545
  year: 2010
  ident: 137_CR23
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2010.02990.x
– volume: 49
  start-page: 796
  year: 2015
  ident: 137_CR280
  publication-title: Ann. Pharmacother.
  doi: 10.1177/1060028015581848
– volume: 36
  start-page: 18
  year: 2016
  ident: 137_CR290
  publication-title: J. Clin. Psychopharmacology
  doi: 10.1097/JCP.0000000000000434
– volume: 375
  start-page: 2504
  year: 2016
  ident: 137_CR320
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc1610047
– volume: 24
  start-page: 1334
  year: 2015
  ident: 137_CR77
  publication-title: Pharmacoepidemiology Drug Saf.
  doi: 10.1002/pds.3901
– volume: 37
  start-page: 483
  year: 2017
  ident: 137_CR341
  publication-title: Med. Decis. Mak.
  doi: 10.1177/0272989X16683928
– volume: 2
  year: 2019
  ident: 137_CR193
  publication-title: JAMA Netw. Open
  doi: 10.1001/jamanetworkopen.2019.6373
– volume: 99
  start-page: 697
  year: 2004
  ident: 137_CR217
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2004.00752.x
– volume: 28
  start-page: 321
  year: 2005
  ident: 137_CR210
  publication-title: J. Subst. Abuse Treat.
  doi: 10.1016/j.jsat.2005.02.007
– volume: 113
  start-page: 729
  year: 2018
  ident: 137_CR344
  publication-title: Addiction
  doi: 10.1111/add.14053
– volume: 14
  start-page: 130
  year: 2009
  ident: 137_CR118
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2008.00142.x
– volume: 566
  start-page: 348
  year: 1991
  ident: 137_CR113
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(91)91724-F
– volume: 14
  start-page: 1
  year: 2003
  ident: 137_CR159
  publication-title: Neuroreport
  doi: 10.1097/00001756-200301200-00001
– volume: 171
  start-page: 39
  year: 2017
  ident: 137_CR88
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2016.11.029
– volume: 68
  start-page: 388
  year: 2019
  ident: 137_CR204
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm6817a3
– volume: 408
  start-page: 720
  year: 2000
  ident: 137_CR106
  publication-title: Nature
  doi: 10.1038/35047086
– volume: 17
  year: 2017
  ident: 137_CR68
  publication-title: BMC Psychiatry
  doi: 10.1186/s12888-017-1323-1
– volume: 146
  start-page: 17
  year: 2015
  ident: 137_CR177
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.09.782
– volume: 243
  start-page: 91
  year: 1982
  ident: 137_CR96
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(82)91123-4
– volume: 28
  start-page: 142
  year: 2009
  ident: 137_CR54
  publication-title: Drug Alcohol Rev.
  doi: 10.1111/j.1465-3362.2008.00042.x
SSID ssj0001586986
Score 2.59875
SecondaryResourceType review_article
Snippet Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3
SubjectTerms 631/378/1662
631/378/1689/5
631/378/3920
Alcohol
Biomedical research
Cancer Research
Councils
Drug abuse
Drug addiction
Drug overdose
Epidemiology
Grants
Humans
Internal Medicine
Medical Microbiology
Medical research
Medicare
Medicine
Medicine & Public Health
Narcotic Antagonists - therapeutic use
Narcotics
Opiate Substitution Treatment - methods
Opioid-Related Disorders - physiopathology
Opioid-Related Disorders - prevention & control
Opioid-Related Disorders - therapy
Pharmaceutical industry
Primer
Public health
Quality of life
Quality of Life Research
Research centers
Scholarships & fellowships
Substance abuse treatment
Substance use disorder
Systematic review
Title Opioid use disorder
URI https://link.springer.com/article/10.1038/s41572-019-0137-5
https://www.ncbi.nlm.nih.gov/pubmed/31919349
https://www.proquest.com/docview/2342379410
https://www.proquest.com/docview/3103047271
https://www.proquest.com/docview/2336246726
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB7Ugggi3karRPDBg2CS3WSzT6JiEUEtYqFvIdkDBGmrbf-_M8mmRTyed7MsM7Nz5xuAEwp00JLYQIqCApRSBFLbODAhL20qGa_hmh6f0vsef-gnfZdwG7u2ykYnVopaDxXlyC9jgqpD4YnCq9FHQFOjqLrqRmgsQougy0iqRV_McyxJlsosbYqZLLsco70S1ItATUJMBMl3c_TDx_xRH63MTmcd1py_6F_XDN6ABTPYhOVHVxHfhNU67-bXvxNtQft59DZ80_50bHztkDX90y6B-H-ebUOvc_d6ex-4CQiBwrc1CSKVhSpjpYwjW6JjJYwwkQlNzItEoi_CWVkIoTU6cUwVmU2ztLQCd3AjLdOc7cDSYDgwe-BLDAU1U2ERK8Ytoeoxy0xqlY4xZIq4B2FDiFw5eHCaUvGeV2VqluU17XKkXU60yxMPzmefjGpsjP82txvq5u6ZjPM5U39drmagoSyJyIPj2TLKPxU1ioEZTukINMGo7ePUg92aabPLoHpB_5RLDy4aLs4P__Om-__f9ABWYoq5KQ0j27A0-ZyaQ3RMJuVRJX1H0Lq5e-q-fAFc_9rH
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bSxwxFD5YC60g0trb6NZOQcEqgzNJZjJ5KKXUylpd64PCvsWZXECQ3a27i_in-ht7zlx2KV7efM6FcPIl37kk5wBskqGDTOIjJQsyUEoZKetZ5GJR-kxxUadr6p1k3XPxq5_2F-Bv-xeGnlW2d2J1UduhIR_5HqNUdQieJP42-hNR1SiKrrYlNGpYHLnbGzTZxl8P93F_txg7-Hn2oxs1VQUig3idRInJY5PzUrHEl6isSCdd4mLHRJEq5HfBy0JKa1Ex4qbIfZZnpZfYQzjluRUc530Gz5F4YzL2ZF_OfTppnqk8a4OnPN8bIz9KevtAj5K4jNL_6e-OTnsnHlvR3MErWGn00_B7DajXsOAGq_Ci10TgV2G59vOF9felN9D5PbocXtpwOnahbTJ5htunVDTg-stbOH8S2byDxcFw4D5AqND0tNzEBTNceMrixz13mTeWoYmWiADiVhDaNOnIqSrGla7C4jzXtew0yk6T7HQawM5syKjOxfFY504rXd0cy7Geg-je5qrmGmJXJgF8njXjeaMgSjFwwylNgZSP7MKyAN7XmzZbDF5nqA8LFcBuu4vzyR9c6drjK_0EL7tnvWN9fHhytA5LjOx9cgGpDixOrqfuIypFk3KjQmIIF08N_X8ZhxWb
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opioid+use+disorder&rft.jtitle=Nature+reviews.+Disease+primers&rft.au=Strang%2C+John&rft.au=Volkow%2C+Nora+D&rft.au=Degenhardt%2C+Louisa&rft.au=Hickman%2C+Matthew&rft.date=2020-01-09&rft.issn=2056-676X&rft.eissn=2056-676X&rft.volume=6&rft.issue=1&rft.spage=3&rft_id=info:doi/10.1038%2Fs41572-019-0137-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2056-676X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2056-676X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2056-676X&client=summon